No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
1825 |
6. Filter based on genotype QC (FinnGen only) |
1825 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Immunodeficiencies
based on the number of shared cases.
Similar with more cases:
- Certain disorders involving the immune mechanism
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 10839 | 6244 | 4540 |
| Only index persons | 9278 | 5498 | 3780 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.16 | 0.18 | 0.13 |
| Only index persons | 0.18 | 0.20 | 0.14 |
| Median age at first event (years) | |||
| Whole population | 48.68 | 49.36 | 47.54 |
| Only index persons | 47.60 | 48.42 | 46.40 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1825 | 1165 | 660 |
| Unadjusted period prevalence (%) | 0.36 | 0.40 | 0.29 |
| Median age at first event (years) | 50.23 | 48.00 | 54.16 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1657
- Matched controls
- 16568
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
+∞
323.0
329
*
120
Kela drug reimbursment
Hypogammaglobulinaemia
+∞
277.0
258
*
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
+∞
269.3
251
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
+∞
248.3
232
*
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
+∞
238.4
223
*
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
+∞
200.1
188
*
H02AB06
ATC
prednisolone; systemic
4.3
169.5
1114
5312
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.3
166.0
1029
4607
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
11.3
153.4
306
325
D81.4
ICD-10 Finland
Nezelof syndrome
+∞
151.4
143
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
11.5
151.3
299
311
ZX120
NOMESCO Finland
Intravenous
6.7
147.5
422
803
J01MA12
ATC
levofloxacin; systemic
4.8
140.5
566
1605
D80.2
ICD-10 Finland
Selective deficiency of immunoglobulin A [IgA]
1431.9
137.5
132
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.3
132.8
619
2009
J01MA14
ATC
moxifloxacin; systemic
6.8
129.4
362
657
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
+∞
118.1
112
*
TPH04
NOMESCO Finland
Cathetrisation of vein
4.0
115.9
581
1969
WW200
NOMESCO Finland
Immunization
12.4
113.8
214
196
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
6.1
111.4
337
667
6BA02
NOMESCO Finland
NA
74.9
110.2
125
18
R50.9
ICD-10 Finland
Fever, unspecified
4.4
110.2
468
1349
TDM10
NOMESCO Finland
Puncture of maxillary antrum
9.3
108.3
238
293
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.5
107.1
446
1256
D84.18
ICD-10 Finland
Other specified defect in the complement system
+∞
106.4
101
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
10.1
106.1
222
250
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
12.8
105.6
195
171
D81.0
ICD-10 Finland
Severe combined immunodeficiency [SCID] with reticular dysgenesis
+∞
103.2
98
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.3
102.0
687
2894
J47
ICD-10 Finland
Bronchiectasis
24.5
99.0
142
63
D83.9
ICD-10 Finland
Common variable immunodeficiency, unspecified
+∞
92.6
88
*
D84.9
ICD-10 Finland
Immunodeficiency, unspecified
904.9
88.5
86
*
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
6.6
86.3
239
413
J45.9
ICD-10 Finland
Asthma, unspecified
3.5
85.1
480
1717
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
+∞
83.0
79
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
5.6
82.1
259
527
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.8
81.5
305
750
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
5.3
81.4
271
587
UGC12
NOMESCO Finland
Flexible bronchoscopy
5.4
79.5
259
546
J01.0
ICD-10 Finland
Acute maxillary sinusitis
3.1
79.5
554
2299
R03DC03
ATC
montelukast; oral
3.4
78.0
448
1610
H02AB07
ATC
prednisone; oral
3.7
77.9
392
1266
J01FF01
ATC
clindamycin; systemic
2.9
75.7
608
2755
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.8
75.0
675
3277
Z3231
NOMESCO Finland
Registered nurse
2.8
73.8
633
2978
Z01.8
ICD-10 Finland
Other specified special examinations
3.1
73.2
516
2134
J01MA02
ATC
ciprofloxacin; systemic
2.7
73.1
761
4017
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.9
71.4
213
401
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
3.1
70.3
476
1908
J45.0
ICD-10 Finland
Predominantly allergic asthma
4.3
70.2
288
768
J01FA06
ATC
roxithromycin; oral
2.6
69.9
814
4537
J45.1
ICD-10 Finland
Nonallergic asthma
4.9
69.8
250
581
TGC00
NOMESCO Finland
Bronchial lavation
10.6
68.5
137
139
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.1
67.1
436
1688
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
7.2
67.0
172
264
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.5
66.7
1010
6420
D84.1
ICD-10 Finland
Defects in the complement system
+∞
66.1
63
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
4.9
64.9
231
531
ZXE10
NOMESCO Finland
More than one and less than three hours
2.5
64.6
742
4049
C03CA01
ATC
furosemide; systemic
2.8
64.2
513
2270
C01CA24
ATC
epinephrine; parenteral
4.8
63.4
230
539
N02AX02
ATC
tramadol; systemic, rectal
2.4
62.5
796
4559
R03AC02
ATC
salbutamol; inhalant
2.4
61.1
1017
6646
D84.19
ICD-10 Finland
Unspecified defect in the complement system
+∞
60.8
58
*
Z3226
NOMESCO Finland
Physiotherapist
2.9
60.6
451
1894
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.3
59.4
345
1219
R03AK06
ATC
salmeterol and fluticasone; inhalant
3.3
58.3
343
1220
H02AB09
ATC
hydrocortisone; systemic
8.6
58.1
131
164
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
57.7
583
2920
XW000
NOMESCO Finland
Bone marrow biopsy
6.5
57.7
158
264
Z2221
NOMESCO Finland
Medical doctor
2.5
57.3
608
3123
H02AB04
ATC
methylprednisolone; systemic
3.1
55.4
355
1340
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.3
55.0
224
586
R4110
NOMESCO Finland
Physiotherapy
2.5
54.1
547
2722
ZXD05
NOMESCO Finland
Urgent procedure
2.4
54.0
632
3394
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.9
53.1
239
684
UJF32
NOMESCO Finland
Coloscopy
2.5
52.3
516
2522
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.2
51.4
866
5490
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.9
50.8
227
644
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.3
50.0
281
959
XF400
NOMESCO Finland
ECG with 12 standard connections
2.9
49.8
353
1414
R03BA02
ATC
budesonide; inhalant
2.7
49.2
403
1762
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
5.9
49.0
143
259
D81.8
ICD-10 Finland
Other combined immunodeficiencies
+∞
48.1
46
*
J01DB01
ATC
cefalexin; oral
2.6
48.1
1409
11378
A07AA02
ATC
nystatin; oral
4.5
48.1
183
446
R06.0
ICD-10 Finland
Dyspnoea
2.5
47.9
473
2295
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.7
47.5
386
1678
JN4BD
NOMESCO Finland
Extensive body CT
3.4
47.2
254
837
R01AD08
ATC
fluticasone; nasal
2.3
46.2
568
3065
R03BB04
ATC
tiotropium bromide; inhalant
3.6
46.0
231
720
A02BC02
ATC
pantoprazole; systemic
2.1
45.6
1090
7867
J01FA10
ATC
azithromycin; systemic
2.1
45.2
1060
7574
N02AA05
ATC
oxycodone; systemic
3.0
44.5
292
1104
J05AB11
ATC
valaciclovir; oral
2.9
44.2
306
1199
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
44.0
676
4021
ZXE20
NOMESCO Finland
More than three and less than five hours
2.9
43.8
303
1183
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.2
43.8
176
451
R01AD09
ATC
mometasone; nasal
2.1
43.3
834
5445
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.8
43.3
154
349
D80.6
ICD-10 Finland
Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia
+∞
42.9
41
*
D83.1
ICD-10 Finland
Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
+∞
42.9
41
*
ZXA10
NOMESCO Finland
Bilateral
2.5
42.9
387
1771
GD1AD
NOMESCO Finland
Thorax CT examination
5.6
42.8
130
247
R03BA05
ATC
fluticasone; inhalant
2.5
42.5
399
1865
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.2
42.4
173
449
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.4
42.1
225
734
J01DA01
ATC
[U] cefalexin; systemic
2.1
41.6
1086
7968
J32.4
ICD-10 Finland
Chronic pansinusitis
10.1
41.5
84
87
J46
ICD-10 Finland
Status asthmaticus
6.7
41.4
109
172
N03AX16
ATC
pregabalin; oral
2.3
41.0
453
2294
J02AC01
ATC
fluconazole; systemic
2.1
40.9
752
4778
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.2
40.9
548
3044
P01AB01
ATC
metronidazole; oral, rectal
2.1
40.4
723
4535
R03AC12
ATC
salmeterol; inhalant
4.9
40.2
138
301
UJF30
NOMESCO Finland
Ileoscopy through colon
3.2
40.2
230
788
ZXA00
NOMESCO Finland
Right side
2.2
40.1
493
2627
XG410
NOMESCO Finland
Flow-volume spirometry
5.0
40.0
135
289
XQ800
NOMESCO Finland
Prick test
3.3
39.6
216
714
J01AA02
ATC
doxycycline; systemic
2.2
39.5
1290
10256
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
39.0
712
4482
WW500
NOMESCO Finland
Blood transfusion
5.4
38.8
121
237
Z2446
NOMESCO Finland
Social worker
3.5
38.6
195
607
A03FA01
ATC
metoclopramide; systemic, rectal
2.3
38.6
412
2046
M05BA04
ATC
alendronic acid; oral
3.6
38.5
188
569
X59
ICD-10 Finland
Exposure to unspecified factor
2.4
38.2
378
1803
M04AA01
ATC
allopurinol; systemic
3.0
37.8
236
856
D84.8
ICD-10 Finland
Other specified immunodeficiencies
+∞
37.6
36
*
ZX108
NOMESCO Finland
Inhalation
15.3
37.3
62
42
ZXE00
NOMESCO Finland
One hour or less
2.0
36.5
737
4790
L04AX01
ATC
azathioprine; systemic
4.4
36.4
140
343
L03AA02
ATC
filgrastim; parenteral
6.0
36.2
104
184
R03DA04
ATC
theophylline; systemic, rectal
4.3
35.9
141
352
T78.3
ICD-10 Finland
Angioneurotic oedema
10.1
35.7
72
74
J01FA09
ATC
clarithromycin; systemic
2.0
35.7
597
3595
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.0
35.6
232
863
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.2
35.2
207
718
ZXA05
NOMESCO Finland
Left side
2.2
35.2
450
2417
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.2
35.0
200
679
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.8
34.8
156
439
J45.8
ICD-10 Finland
Mixed asthma
5.4
34.7
108
211
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
13.8
34.6
60
45
L04AA06
ATC
mycophenolic acid; systemic
8.2
34.6
79
101
D84.0
ICD-10 Finland
Lymphocyte function antigen-1 [LFA-1] defect
+∞
34.5
33
*
D83.8
ICD-10 Finland
Other common variable immunodeficiencies
+∞
34.5
33
*
R03AC13
ATC
formoterol; inhalant
4.3
34.1
134
335
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
14.3
34.0
58
42
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
94.6
33.8
37
*
J01FA15
ATC
telithromycin; oral
2.8
33.8
237
923
D84.11
ICD-10 Finland
Hereditary angioedema type I
+∞
33.4
32
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.0
33.2
613
3810
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.9
33.1
227
872
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
5.8
32.8
96
174
TAB00
NOMESCO Finland
Lumbar puncture
4.2
32.7
129
323
L04AA01
ATC
[U] ciclosporin; systemic
9.9
32.5
66
69
A01AB09
ATC
miconazole; local oral
3.1
32.5
198
704
D81.9
ICD-10 Finland
Combined immunodeficiency, unspecified
+∞
32.4
31
*
127
Kela drug reimbursment
Transplant complication
8.7
32.4
71
85
A41.9
ICD-10 Finland
Sepsis, unspecified
5.1
32.1
105
217
A46
ICD-10 Finland
Erysipelas
2.6
32.1
254
1065
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.8
31.9
223
866
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.4
31.7
313
1476
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
4.1
31.6
129
334
R03BB01
ATC
ipratropium bromide; inhalant
5.1
31.3
103
214
H04.10
ICD-10 Finland
Dry eye syndrome
2.9
31.3
213
813
R06AE07
ATC
cetirizine; oral
1.9
31.3
777
5337
N02BE01
ATC
paracetamol; systemic, rectal
2.1
31.3
1390
11746
J01DA06
ATC
[U] cefuroxime; systemic
2.4
31.3
298
1378
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
7.2
31.2
77
111
N05CF01
ATC
zopiclone; oral
2.0
31.2
530
3174
WX002
NOMESCO Finland
Sedation and analgesia
2.2
30.9
357
1813
R01AD05
ATC
budesonide; nasal
3.1
30.9
186
655
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
4.0
30.9
130
346
SPAT1262
SPAT
Handing over of treatment supplies
2.3
30.9
332
1632
ZX112
NOMESCO Finland
Subcutaneous
6.7
30.8
80
124
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.6
30.8
252
1075
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
14.1
30.4
52
38
D70.82
ICD-10 Finland
Drug-induced neutropenia
8.6
30.4
67
81
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.2
30.3
167
553
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
10.9
30.1
58
55
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.8
30.0
214
841
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.4
30.0
92
177
A02BC01
ATC
omeprazole; systemic
2.0
29.9
491
2891
R03AK07
ATC
formoterol and budesonide; inhalant
2.2
29.8
369
1930
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.6
29.7
248
1068
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
29.5
408
2239
J05AB01
ATC
aciclovir; systemic
2.1
29.3
392
2122
J31.0
ICD-10 Finland
Chronic rhinitis
3.0
29.3
182
655
M36.8*D80.1
ICD-10 Finland
Systemic disorders of connective tissue in hypogammaglobulinaemia
+∞
29.2
28
*
338
Kela drug reimbursment
C1-esterase inhibitor, icatibant and conestat alfa
+∞
29.2
28
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
9.4
28.8
60
66
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
28.7
764
5321
P01BA02
ATC
hydroxychloroquine; oral
3.0
28.7
179
646
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.3
28.5
303
1474
SPAT1255
SPAT
Intravenous administration of medicine
3.5
28.3
141
432
R03BA08
ATC
ciclesonide; inhalant
2.9
28.2
187
699
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.6
28.0
224
940
A02BC05
ATC
esomeprazole; systemic
1.8
27.8
673
4524
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
5.7
27.7
82
151
E0000UV
ATC
NA
1.8
27.6
687
4657
B01AB05
ATC
enoxaparin; parenteral
1.9
27.5
489
2951
D84.13
ICD-10 Finland
Hereditary angioedema type III
+∞
27.2
26
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.1
26.9
355
1898
R03DC01
ATC
zafirlukast; oral
6.9
26.6
67
100
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
17.5
26.2
41
24
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
5.0
26.2
87
183
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.9
26.1
66
99
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.3
26.1
264
1252
R05
ICD-10 Finland
Cough
2.1
25.9
361
1971
A02BC03
ATC
lansoprazole; oral
1.9
25.9
495
3052
R03AK08
ATC
formoterol and beclometasone; inhalant
4.0
25.6
105
273
WZC30
NOMESCO Finland
Teaching
2.3
25.5
250
1165
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
7.4
25.4
61
85
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
3.5
25.3
122
364
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.8
25.3
642
4343
R03AC03
ATC
terbutaline; inhalant
2.3
25.2
267
1292
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.8
25.1
112
314
B06AC02
ATC
icatibant; parenteral
+∞
25.1
24
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.9
24.9
161
592
WX892
NOMESCO Finland
Monitored bed care
2.9
24.7
159
582
C07AB07
ATC
bisoprolol; oral
1.8
24.6
677
4685
A04AA01
ATC
ondansetron; systemic, rectal
3.0
24.5
150
533
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
24.5
682
4738
R06AE09
ATC
levocetirizine; oral
2.2
24.4
283
1427
N05BA01
ATC
diazepam; systemic, rectal
2.3
24.4
241
1127
L04AD01
ATC
ciclosporin; systemic
6.3
24.4
66
109
A06AD11
ATC
lactulose; oral
2.3
24.3
240
1122
R03BA01
ATC
beclometasone; inhalant
2.2
24.2
262
1277
R81
ICPC
Pneumonia
5.0
24.2
80
168
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
8.0
24.1
55
71
N03AX12
ATC
gabapentin; oral
2.2
24.1
283
1434
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
11.9
24.0
44
38
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
24.0
500
3162
A06AC01
ATC
ispaghula (psylla seeds); oral
1.9
23.9
398
2324
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.6
23.9
190
792
R51.80
ICD-10 Finland
Headache
2.1
23.8
291
1501
Z31.5
ICD-10 Finland
Genetic counselling
3.2
23.7
129
422
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.4
23.7
120
372
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.5
23.6
85
195
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.4
23.6
219
992
JN4AD
NOMESCO Finland
Body CT examination
3.0
23.2
140
493
D86.0
ICD-10 Finland
Sarcoidosis of lung
8.3
23.0
51
63
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
3.7
22.8
102
286
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.7
22.8
167
662
UJF92
NOMESCO Finland
Capsular endoscopy
5.3
22.7
71
140
J20
ICD-10 Finland
Acute bronchitis
2.5
22.5
191
825
J01CA04
ATC
amoxicillin; systemic
1.8
22.4
1339
11527
JN3AD
NOMESCO Finland
Abdominal CT examination
2.8
22.4
149
558
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.4
22.2
197
870
R53
ICD-10 Finland
Malaise and fatigue
2.0
22.2
341
1924
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.0
22.0
315
1729
Z3229
NOMESCO Finland
Other healthcare associate professional
2.6
21.9
176
737
2790B
ICD-9 Finland
Disorders involving the immune mechanism, Deficiency of humoral immunity[DEFICIENTIA IMMUNOGLOBULINI A]
+∞
21.9
21
*
L28
ICPC
Limited function/disability (L)
2.2
21.9
245
1211
R06AX27
ATC
desloratadine; oral
1.8
21.8
486
3119
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
4.8
21.8
73
156
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
4.2
21.7
85
212
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
21.7
290
1545
GD1DG
NOMESCO Finland
Extremely extensive MRI examination of pleura with high field magnet
81.2
21.7
24
*
R03AK11
ATC
formoterol and fluticasone; inhalant
5.1
21.4
69
141
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.3
21.4
80
191
D64.9
ICD-10 Finland
Anaemia, unspecified
2.6
21.4
164
669
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.8
21.3
144
543
J01.1
ICD-10 Finland
Acute frontal sinusitis
6.0
21.3
59
101
J01.4
ICD-10 Finland
Acute pansinusitis
11.7
21.3
39
34
XG474
NOMESCO Finland
Exhalation nntrogen oxide
4.0
21.2
86
222
R01AD12
ATC
fluticasone furoate; nasal
1.7
21.2
517
3410
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
6.8
21.0
53
80
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.8
20.9
140
527
D70.89
ICD-10 Finland
Neutropenic splenomegaly
6.9
20.9
52
77
A07AA09
ATC
vancomycin; oral
8.0
20.8
47
60
N06AX21
ATC
duloxetine; oral
2.3
20.8
208
975
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.3
20.7
106
332
N06AA09
ATC
amitriptyline; systemic
2.4
20.7
192
865
B99
ICD-10 Finland
Other and unspecified infectious diseases
6.0
20.7
57
97
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
5.6
20.7
61
113
1XC02
NOMESCO Finland
NA
10.5
20.6
40
39
XA800
NOMESCO Finland
Neuropsychological investigation
3.3
20.6
108
344
R60.0
ICD-10 Finland
Localized oedema
2.4
20.6
184
815
A28
ICPC
Limited function/disability NOS
2.2
20.6
221
1072
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
10.2
20.4
40
40
J01DA08
ATC
[U] cefaclor; oral
2.2
20.4
215
1033
A02BA02
ATC
ranitidine; systemic
1.9
20.2
319
1811
ZX114
NOMESCO Finland
Intramuscular
6.0
20.2
56
96
I50.9
ICD-10 Finland
Heart failure, unspecified
2.4
20.2
181
800
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
6.0
19.9
55
94
D81.2
ICD-10 Finland
Severe combined immunodeficiency [SCID] with low or normal B-cell numbers
+∞
19.8
19
*
J45
ICD-10 Finland
Asthma
2.4
19.8
184
829
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.1
19.6
112
379
TK800
NOMESCO Finland
Hemodialysis
5.3
19.6
60
116
B29
ICPC
Lymph/immune mech sympt/complt other
19.6
19.5
29
15
M25.5
ICD-10 Finland
Pain in joint
1.7
19.4
463
3018
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.2
19.4
223
1111
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.6
19.4
88
251
C03DA01
ATC
spironolactone; oral
2.4
19.2
167
727
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.9
19.2
302
1708
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
20.3
19.1
28
14
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.4
19.0
171
756
J32.1
ICD-10 Finland
Chronic frontal sinusitis
15.0
18.9
31
21
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
6.5
18.9
49
77
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
3.5
18.9
90
267
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.5
18.8
160
690
D82.1
ICD-10 Finland
Di George syndrome
+∞
18.8
18
*
D82.4
ICD-10 Finland
Hyperimmunoglobulin E [IgE] syndrome
+∞
18.8
18
*
D81.1
ICD-10 Finland
Severe combined immunodeficiency [SCID] with low T- and B-cell numbers
+∞
18.8
18
*
2790C
ICD-9 Finland
Disorders involving the immune mechanism, Deficiency of humoral immunity[DEFICIENTIA IMMUNOGLOBULINI ALIA]
+∞
18.8
18
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
12.4
18.6
33
27
390
Kela drug reimbursment
Ibrutinib
192.1
18.6
19
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.7
18.6
448
2922
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.6
18.5
140
566
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
5.1
18.5
58
116
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.5
18.4
154
657
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.2
18.4
212
1056
X57
ICD-10 Finland
Unspecified privation
4.6
18.4
64
143
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.3
18.3
177
814
UKC02
NOMESCO Finland
Cystoscopy
2.1
18.3
230
1191
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
3.4
18.3
89
269
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
25.3
18.2
25
10
R01BA52
ATC
pseudoephedrine, combinations; oral
1.7
18.2
504
3417
ZY010
NOMESCO Finland
Hospital outpatient
2.9
18.1
116
425
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
3.7
18.0
80
224
AA1AD
NOMESCO Finland
CT of head and brain
1.8
18.0
344
2080
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
17.9
402
2561
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
10.2
17.9
35
35
H65.3
ICD-10 Finland
Chronic mucoid otitis media
4.0
17.9
72
185
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
7.8
17.9
41
54
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
4.5
17.8
64
148
D82.2
ICD-10 Finland
Immunodeficiency with short-limbed stature
+∞
17.7
17
*
1512
Kela drug reimbursment
Ibrutinib
+∞
17.7
17
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.3
17.7
92
292
GD1CG
NOMESCO Finland
Extensive examination of lungs and pleura with high intensity magnet
37.1
17.6
22
6
R4120
NOMESCO Finland
Occupational therapy
2.7
17.6
128
507
RS221
NOMESCO Finland
NA
6.0
17.4
48
82
A41.8
ICD-10 Finland
Other specified sepsis
6.7
17.4
44
67
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.1
17.4
201
1002
J32.8
ICD-10 Finland
Other chronic sinusitis
24.3
17.3
24
10
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.9
17.3
106
378
ZX121
NOMESCO Finland
Central venous catheter
11.2
17.2
32
29
L04AA13
ATC
leflunomide; oral
4.0
17.2
69
177
Z50.1
ICD-10 Finland
Other physical therapy
2.9
17.2
109
396
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
4.4
17.2
62
144
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
5.9
17.1
48
84
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.7
17.1
443
2937
R06AX22
ATC
ebastine; oral
1.9
17.0
292
1699
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
5.5
17.0
50
93
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.8
17.0
353
2190
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
25.9
16.9
23
9
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
3.5
16.8
79
232
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
7.3
16.8
40
56
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
16.7
360
2255
ZYC01
NOMESCO Finland
Remote contact by phone
3.1
16.7
95
320
J06BA02
ATC
immunoglobulins, normal human, for intravascular adm.; systemic
+∞
16.7
16
*
D80.4
ICD-10 Finland
Selective deficiency of immunoglobulin M [IgM]
+∞
16.7
16
*
B02AA02
ATC
tranexamic acid; systemic
1.9
16.6
260
1464
S01GX01
ATC
cromoglicic acid; ophthalmic
1.8
16.6
347
2155
R1250
NOMESCO Finland
Evaluation of functional capability
4.5
16.6
59
135
UDM02
NOMESCO Finland
Sinoscopy
4.1
16.6
64
159
B34.9
ICD-10 Finland
Viral infection, unspecified
3.7
16.6
74
209
L01XE27
ATC
[U] ibrutinib; oral
171.6
16.5
17
*
M05BB03
ATC
alendronic acid and colecalciferol; oral
4.9
16.4
54
114
J01FA01
ATC
erythromycin; systemic
1.9
16.4
247
1369
A12AA04
ATC
calcium carbonate; oral
5.8
16.4
46
81
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
7.2
16.3
39
55
TPH07
NOMESCO Finland
Cathetrisation of artery
2.2
16.3
173
830
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
3.0
16.3
98
344
A07EA06
ATC
budesonide; oral, local oral
3.5
16.2
77
229
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.7
16.1
111
425
J01DC02
ATC
cefuroxime; systemic
2.6
16.1
121
488
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
11.8
16.1
29
25
H65.2
ICD-10 Finland
Chronic serous otitis media
5.5
15.9
47
88
B01AA03
ATC
warfarin; systemic
1.9
15.9
257
1462
M05BA07
ATC
risedronic acid; oral
4.0
15.8
64
166
Z94.0
ICD-10 Finland
Kidney transplant status
6.9
15.8
39
58
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
8.4
15.8
34
41
WX872
NOMESCO Finland
Intensive care
3.1
15.7
90
306
M35.7
ICD-10 Finland
Hypermobility syndrome
5.3
15.6
47
90
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
17.4
15.6
24
14
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
5.0
15.6
50
103
N06AX11
ATC
mirtazapine; oral
1.6
15.6
487
3387
XF600
NOMESCO Finland
Bloodpressure measurement
2.6
15.5
119
486
3XA02
NOMESCO Finland
NA
161.4
15.5
16
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
8.6
15.5
33
39
D07AC01
ATC
betamethasone; topical
1.6
15.5
516
3649
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.1
15.4
189
963
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
4.0
15.4
62
160
L01BB05
ATC
fludarabine; systemic
38.4
15.4
19
5
B01AB04
ATC
dalteparin; parenteral
3.1
15.4
88
299
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
7.1
15.4
37
53
S97
ICPC
Chronic ulcer skin
2.9
15.4
93
328
C10AC01
ATC
colestyramine; oral
3.9
15.3
64
171
G47.3
ICD-10 Finland
Sleep apnoea
1.8
15.3
312
1918
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
4.6
15.2
52
115
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
7.0
15.2
37
54
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
5.9
15.2
42
73
B03XA02
ATC
darbepoetin alfa; parenteral
5.7
15.1
43
77
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
7.9
15.1
34
44
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
7.2
15.1
36
51
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.3
15.1
78
248
RD210
NOMESCO Finland
NA
4.0
15.0
60
154
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.4
15.0
130
565
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
14.1
15.0
25
18
A01AB04
ATC
amphotericin B; local oral
2.8
15.0
96
351
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.1
15.0
176
884
C82.1
ICD-10 Finland
Follicular lymphoma grade II
10.9
15.0
28
26
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
7.4
15.0
35
48
L03AA13
ATC
pegfilgrastim; parenteral
3.1
15.0
81
266
KA1AE
NOMESCO Finland
Kidney ultrasound examination
4.3
14.9
55
131
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.2
14.9
162
786
D07AB02
ATC
hydrocortisone butyrate; topical
1.6
14.8
434
2957
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.2
14.8
80
262
R60.9
ICD-10 Finland
Oedema, unspecified
3.0
14.8
87
302
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.0
14.8
87
303
Z49.1
ICD-10 Finland
Extracorporeal dialysis
6.2
14.7
39
64
SPAT1325
SPAT
Vaccination
1.6
14.7
531
3816
WX110
NOMESCO Finland
Local anesthesy
1.5
14.7
1087
9201
N03AX11
ATC
topiramate; oral
3.9
14.6
60
158
T78.4
ICD-10 Finland
Allergy, unspecified
2.8
14.6
98
369
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.6
14.6
107
426
N30.0
ICD-10 Finland
Acute cystitis
1.9
14.6
220
1217
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.6
14.6
65
184
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
14.3
14.5
24
17
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.4
14.5
132
588
D82.8
ICD-10 Finland
Immunodeficiency associated with other specified major defects
151.3
14.5
15
*
WX722
NOMESCO Finland
PEEP
2.9
14.4
92
334
Z2445
NOMESCO Finland
Psychologist
2.7
14.4
98
374
R75
ICPC
Sinusitis acute/chronic
2.9
14.3
90
327
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.4
14.3
123
535
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.2
14.2
148
704
R06AX13
ATC
loratadine; oral
1.8
14.2
262
1555
C08CA01
ATC
amlodipine; oral
1.6
14.2
461
3221
E86
ICD-10 Finland
Volume depletion
4.8
14.2
47
101
C08DA01
ATC
verapamil; systemic
3.2
14.1
75
243
R01AD01
ATC
beclometasone; nasal
1.8
14.1
253
1488
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.3
14.1
135
619
X58
ICD-10 Finland
Exposure to other specified factors
1.9
14.1
232
1327
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.6
14.0
474
3345
DPA30
NOMESCO Finland
Sphenotomy
11.0
14.0
26
24
WX882
NOMESCO Finland
High dependency care
3.2
14.0
75
245
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
10.1
14.0
27
27
N05BA04
ATC
oxazepam; oral
1.6
13.9
378
2520
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.3
13.9
128
574
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
13.9
431
2975
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
7.9
13.9
31
40
M01AE03
ATC
ketoprofen; systemic, rectal
1.5
13.9
559
4113
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.7
13.8
347
2264
N05CD07
ATC
temazepam; oral
2.0
13.8
187
992
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
6.8
13.8
34
51
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
7.4
13.7
32
44
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
13.7
13.7
23
17
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
9.2
13.7
28
31
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
9.8
13.7
27
28
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.3
13.6
127
574
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
5.0
13.6
43
88
E000001
ATC
NA
1.7
13.6
330
2131
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.9
13.6
81
285
D84.12
ICD-10 Finland
Hereditary angioedema type II
+∞
13.6
13
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.8
13.5
87
319
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
5.5
13.5
39
72
4930B
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]
9.4
13.5
27
29
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
16.3
13.5
21
13
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
4.1
13.4
51
126
A11CC03
ATC
alfacalcidol; systemic
4.1
13.4
52
131
C83.1
ICD-10 Finland
Mantle cell lymphoma
18.4
13.4
20
11
ZX110
NOMESCO Finland
Intracutaneous
26.0
13.4
18
7
XCK10
NOMESCO Finland
Photography of fundus of eye
2.1
13.4
151
745
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
7.1
13.4
32
46
3AC01
NOMESCO Finland
NA
6.0
13.3
36
61
L01AA01
ATC
cyclophosphamide; systemic
11.6
13.3
24
21
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
6.7
13.3
33
50
B28
ICPC
Limited function/disability (B)
13.9
13.2
22
16
A03
ICPC
Fever
1.7
13.2
279
1730
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
3.4
13.2
64
195
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.4
13.1
113
492
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
4.1
13.1
50
124
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
8.0
13.1
29
37
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
7.2
13.1
31
44
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
4.8
13.1
43
92
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.2
13.0
135
642
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
3.3
13.0
64
197
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
28.6
13.0
17
6
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
28.6
13.0
17
6
Z71.8
ICD-10 Finland
Other specified counselling
1.6
12.9
382
2595
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
19.2
12.9
19
10
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
5.9
12.9
35
60
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.4
12.8
115
509
602
Kela drug reimbursment
Children's severe malnutrition
9.1
12.7
26
29
132
Kela drug reimbursment
Sarcoidosis
9.1
12.7
26
29
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
3.6
12.6
56
159
N06AB04
ATC
citalopram; systemic
1.7
12.6
325
2130
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
5.6
12.6
36
66
M79.6
ICD-10 Finland
Pain in limb
1.5
12.5
526
3887
J01XB01
ATC
colistin; inhalant, parenteral
+∞
12.5
12
*
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.4
12.5
59
176
J01CF05
ATC
flucloxacillin; systemic
3.0
12.5
71
241
C83.00
ICD-10 Finland
Lymphocytic lymphoma
20.2
12.5
18
9
B03XA01
ATC
erythropoietin; parenteral
7.7
12.4
28
37
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.5
12.4
95
387
ND1AA
NOMESCO Finland
Wrist X-ray examination
2.4
12.4
104
444
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.1
12.4
140
692
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
3.8
12.4
52
141
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.4
12.4
104
445
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
3.1
12.4
66
216
NF1AA
NOMESCO Finland
Hip X-ray examination
2.2
12.3
123
574
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
11.7
12.3
22
19
318
Kela drug reimbursment
Teriparatide
10.6
12.3
23
22
R11
ICD-10 Finland
Nausea and vomiting
2.1
12.3
139
688
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
12.2
622
4786
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.7
12.2
301
1947
K90.0
ICD-10 Finland
Coeliac disease
3.3
12.2
60
185
M01CB01
ATC
sodium aurothiomalate; parenteral
5.0
12.2
38
77
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.5
12.2
94
385
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.2
12.1
63
202
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
5.9
12.1
33
57
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.2
12.1
62
197
A07EC01
ATC
sulfasalazine; oral, rectal
2.1
12.1
137
676
L50.9
ICD-10 Finland
Urticaria, unspecified
2.8
12.0
76
278
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
3.6
12.0
53
150
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.7
12.0
52
145
XG466
NOMESCO Finland
Sleep oxymetry
3.2
12.0
61
193
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.8
12.0
211
1232
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.4
11.9
42
97
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
3.3
11.9
59
183
J33.8
ICD-10 Finland
Other polyp of sinus
3.9
11.9
48
126
R13
ICD-10 Finland
Dysphagia
2.4
11.9
98
416
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.4
11.8
99
425
W19
ICD-10 Finland
Unspecified fall
2.0
11.8
146
746
ZXD20
NOMESCO Finland
Day surgery
1.8
11.8
208
1211
H01
ICPC
Ear pain/earache
1.9
11.8
187
1052
B02.9
ICD-10 Finland
Zoster without complication
2.5
11.8
93
387
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
4.4
11.8
42
98
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.2
11.8
62
201
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
8.4
11.8
25
30
M05BX04
ATC
denosumab; parenteral
2.7
11.8
79
300
L04AB04
ATC
adalimumab; parenteral
3.9
11.8
48
127
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.6
11.8
331
2217
A07EC02
ATC
mesalazine; oral, rectal
2.4
11.7
98
420
Y89.9
ICD-10 Finland
Sequelae of unspecified external cause
7.4
11.7
27
37
J01
ICD-10 Finland
Acute sinusitis
2.5
11.7
94
393
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.0
11.7
46
118
K92.1
ICD-10 Finland
Melaena
2.7
11.7
81
313
JN4CD
NOMESCO Finland
Very extensive body CT
3.0
11.7
68
236
R02
ICPC
Shortness of breath/dyspnoea
1.9
11.7
180
1002
D07AC13
ATC
mometasone; topical
1.5
11.6
421
2999
G44.2
ICD-10 Finland
Tension-type headache
1.8
11.6
211
1245
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
5.2
11.5
35
69
M13.9
ICD-10 Finland
Arthritis, unspecified
2.2
11.5
115
537
H05AA02
ATC
teriparatide; parenteral
10.1
11.5
22
22
N19
ICD-10 Finland
Unspecified kidney failure
3.4
11.5
54
161
D81.3
ICD-10 Finland
Adenosine deaminase [ADA] deficiency
+∞
11.5
11
*
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.0
11.4
65
220
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
2.8
11.4
72
263
B05XA03
ATC
sodium chloride; parenteral
120.8
11.4
12
*
E84.0
ICD-10 Finland
Cystic fibrosis with pulmonary manifestations
120.8
11.4
12
*
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.9
11.4
171
944
M81.9
ICD-10 Finland
Osteoporosis, unspecified
3.0
11.4
65
221
K07.60
ICD-10 Finland
Snapping jaw
2.4
11.4
93
394
E000006
ATC
NA
2.2
11.3
121
584
R04.0
ICD-10 Finland
Epistaxis
2.3
11.3
108
493
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.5
11.3
52
153
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2.8
11.3
72
266
EB1WA
NOMESCO Finland
NA
7.3
11.2
26
36
I50.0
ICD-10 Finland
Congestive heart failure
2.5
11.2
86
353
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
3.7
11.2
48
133
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
6.0
11.2
30
51
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
17.2
11.2
17
10
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
11.2
231
1417
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
2.8
11.1
73
271
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
12.8
11.1
19
15
R01BA51
ATC
phenylpropanolamine, combinations; oral
1.8
11.1
190
1095
E000002
ATC
NA
1.8
11.1
190
1096
N06AX16
ATC
venlafaxine; oral
1.7
11.1
224
1365
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.2
11.1
57
182
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
3.7
11.1
47
129
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.7
11.1
74
281
N18.0
ICD-10 Finland
End-stage renal disease
5.9
11.0
30
52
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.6
11.0
80
316
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
11.0
553
4219
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.9
11.0
168
934
J01EA01
ATC
trimethoprim; systemic
1.6
11.0
370
2583
WW300
NOMESCO Finland
Transfer of autologic stem cells
10.1
11.0
21
21
J01MA01
ATC
ofloxacin; systemic
2.1
11.0
130
656
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
5.0
11.0
34
69
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.7
10.9
233
1440
XX3DW
NOMESCO Finland
Time consuming IT work
2.0
10.9
151
807
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.8
10.9
202
1200
R06.2
ICD-10 Finland
Wheezing
2.5
10.8
82
332
H26.3
ICD-10 Finland
Drug-induced cataract
8.3
10.8
23
28
R42
ICD-10 Finland
Dizziness and giddiness
1.6
10.8
304
2031
DMB10
NOMESCO Finland
Radical maxillary antrotomy
8.9
10.8
22
25
5BA08
NOMESCO Finland
NA
8.9
10.8
22
25
K59.1
ICD-10 Finland
Functional diarrhoea
2.5
10.8
86
361
L88
ICPC
Rheumatoid/seropositive arthritis
2.8
10.8
69
256
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.0
10.8
136
702
A05AA02
ATC
ursodeoxycholic acid; oral
4.2
10.7
40
98
N03AE01
ATC
clonazepam; systemic
2.3
10.7
99
445
N05BB01
ATC
hydroxyzine; systemic
2.3
10.7
104
478
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
2.6
10.7
78
309
E87.6
ICD-10 Finland
Hypokalaemia
3.2
10.7
55
176
NFC20
NOMESCO Finland
Secondary implantation of hip prosthesis
4.9
10.7
34
71
C07AB02
ATC
metoprolol; systemic
1.6
10.7
272
1768
TQW99
NOMESCO Finland
Other minor procedure on skin
2.6
10.6
78
312
R5140
NOMESCO Finland
Monitoring the use of the aid
1.9
10.6
149
801
49300
ICD-8 Finland
Asthma, bronchiale
3.7
10.6
45
124
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
4.3
10.6
38
90
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
5.8
10.6
29
51
K29.3
ICD-10 Finland
Chronic superficial gastritis
3.2
10.6
55
178
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
2.9
10.5
63
224
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
9.2
10.5
21
23
S18
ICPC
Laceration/cut
1.4
10.5
582
4521
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
6.6
10.5
26
40
Z49.0
ICD-10 Finland
Preparatory care for dialysis
6.6
10.5
26
40
4224
FHL
Endonasal anthrostomy
5.1
10.5
32
64
J01CF02
ATC
cloxacillin; systemic
3.5
10.5
48
141
J15.8
ICD-10 Finland
Other bacterial pneumonia
7.4
10.5
24
33
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.4
10.4
50
152
A04AA02
ATC
granisetron; systemic, transdermal
2.3
10.4
97
437
D07AD01
ATC
clobetasol; topical
1.7
10.4
224
1389
Q87.06
ICD-10 Finland
Velocardiofacial syndrome
110.7
10.4
11
*
D80.5
ICD-10 Finland
Immunodeficiency with increased immunoglobulin M [IgM]
+∞
10.4
10
*
D82.9
ICD-10 Finland
Immunodeficiency associated with major defect, unspecified
+∞
10.4
10
*
B06AC05
ATC
lanadelumab; parenteral
+∞
10.4
10
*
B06AC01
ATC
c1-inhibitor, plasma derived; parenteral
+∞
10.4
10
*
2790A
ICD-9 Finland
Disorders involving the immune mechanism, Deficiency of humoral immunity[AGAMMAGLOBULINAEMIA (BRUTON)]
+∞
10.4
10
*
H66.9
ICD-10 Finland
Otitis media, unspecified
2.1
10.4
125
632
UDC00
NOMESCO Finland
Ear microscopy
2.1
10.4
117
578
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
4.6
10.4
35
78
TKC20
NOMESCO Finland
Catheterisation of bladder
2.2
10.4
100
461
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.5
10.4
47
137
N03AX09
ATC
lamotrigine; oral
2.4
10.4
86
368
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
3.6
10.3
45
127
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
3.6
10.3
45
127
RS220
NOMESCO Finland
NA
4.4
10.3
36
83
A02BA03
ATC
famotidine; systemic
2.8
10.3
64
232
Z94.2
ICD-10 Finland
Lung transplant status
18.9
10.3
15
8
YNB10
NOMESCO Finland
Collection of stem cells for transplant
18.9
10.3
15
8
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
9.6
10.3
20
21
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
3.0
10.2
56
188
D07AB08
ATC
desonide; topical
1.8
10.2
172
988
D07AA02
ATC
hydrocortisone; topical
1.7
10.2
225
1406
M81.4
ICD-10 Finland
Drug-induced osteoporosis
13.2
10.2
17
13
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
3.6
10.1
45
129
R74
ICPC
Upper respiratory infection acute
1.5
10.1
451
3347
EBA10
NOMESCO Finland
Surgical removal of tooth
1.8
10.1
190
1128
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
5.9
10.1
27
46
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
2.2
10.1
101
474
R06AX26
ATC
fexofenadine; oral
2.1
10.1
114
561
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
7.9
10.1
22
28
J20.0
ICD-10 Finland
Acute bronchitis due to Mycoplasma pneumoniae
7.9
10.1
22
28
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
6.9
10.1
24
35
4222
FHL
Endonasal etmoidectomy
6.9
10.1
24
35
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.8
10.1
64
236
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
3.5
10.1
46
135
S01GX05
ATC
lodoxamide; ophthalmic
4.5
10.1
34
76
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.9
10.1
147
804
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
2.7
10.1
69
267
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.9
10.1
59
207
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
8.5
10.0
21
25
R03BC03
ATC
nedocromil; inhalant
2.1
10.0
116
578
A10AE04
ATC
insulin glargine; parenteral
2.0
10.0
135
717
V03AE02
ATC
sevelamer; oral
9.2
10.0
20
22
J06.80
ICD-10 Finland
Continuously repeating infections of a child
10.1
10.0
19
19
A01
ICPC
Pain general/multiple sites
2.1
10.0
114
567
N05CF02
ATC
zolpidem; oral
1.6
9.9
259
1692
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
2.9
9.9
60
215
J33.0
ICD-10 Finland
Polyp of nasal cavity
3.1
9.9
53
175
L89
ICD-10 Finland
Decubitus ulcer and pressure area
4.9
9.9
31
64
JN6AD
NOMESCO Finland
CT of torso and neck
5.1
9.9
30
60
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
5.1
9.9
30
60
UJD02
NOMESCO Finland
Gastroscopy
2.4
9.8
80
340
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.3
9.8
93
424
SPAT1229
SPAT
Assessment of need for aid
2.1
9.8
114
568
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
20.2
9.8
14
7
XKD00
NOMESCO Finland
Uroflowmetry
1.8
9.8
189
1134
J05AB09
ATC
famciclovir; oral
9.6
9.8
19
20
R33
ICD-10 Finland
Retention of urine
2.2
9.7
95
441
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
5.4
9.7
28
53
WX402
NOMESCO Finland
General anaesthesia
1.6
9.7
258
1698
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.8
9.7
155
876
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.9
9.7
136
733
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
13.4
9.7
16
12
DPA20
NOMESCO Finland
Trephine of frontal sinus
13.4
9.7
16
12
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
5.9
9.7
26
45
A01AB10
ATC
natamycin; local oral
3.1
9.7
52
173
J01GB01
ATC
tobramycin; inhalant, parenteral
55.3
9.7
11
*
K50.9
ICD-10 Finland
Crohn disease, unspecified
3.8
9.6
39
104
212
Kela drug reimbursment
Gout
4.3
9.6
34
80
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.1
9.6
106
518
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.7
9.5
62
233
V03AE01
ATC
polystyrene sulfonate; oral
5.3
9.5
28
54
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
4.0
9.5
37
95
RK110
NOMESCO Finland
NA
6.0
9.5
25
42
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.8
9.5
61
227
J05AH02
ATC
oseltamivir; oral
5.7
9.5
26
46
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.9
9.5
138
752
T81.9
ICD-10 Finland
Unspecified complication of procedure
4.0
9.4
36
91
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
4.0
9.4
36
91
R52.9
ICD-10 Finland
Pain, unspecified
1.9
9.4
132
711
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.0
9.4
122
639
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
9.4
721
5909
M01AH01
ATC
celecoxib; oral (coxibs)
1.6
9.4
249
1635
E84.9
ICD-10 Finland
Cystic fibrosis, unspecified
+∞
9.4
9
*
R31
ICD-10 Finland
Unspecified haematuria
2.0
9.4
118
611
M79.7
ICD-10 Finland
Fibromyalgia
2.7
9.4
63
240
SAA04
NOMESCO Finland
Special inverstigation of mouth
2.1
9.4
100
483
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.8
9.3
150
848
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.8
9.3
150
848
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
3.0
9.3
51
172
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.8
9.2
164
960
M03BX01
ATC
baclofen; systemic
3.8
9.2
38
103
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
4.4
9.2
32
74
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.8
9.2
155
891
R49.08
ICD-10 Finland
Other specified dysphonia
3.4
9.2
43
129
J96.0
ICD-10 Finland
Acute respiratory failure
5.5
9.2
26
48
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
5.5
9.2
26
48
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
5.8
9.2
25
44
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
3.2
9.2
47
151
R05
ICPC
Cough
1.5
9.2
331
2337
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.7
9.2
183
1107
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.7
9.2
60
227
K11.2
ICD-10 Finland
Sialoadenitis
2.8
9.1
57
208
4239
FHL
Other measure in this category
8.3
9.1
19
23
RS224
NOMESCO Finland
NA
8.3
9.1
19
23
G03.9
ICD-10 Finland
Meningitis, unspecified
11.5
9.1
16
14
C90.0
ICD-10 Finland
Multiple myeloma
5.6
9.1
25
45
K50.0
ICD-10 Finland
Crohn disease of small intestine
3.8
9.0
37
100
K90.9
ICD-10 Finland
Intestinal malabsorption, unspecified
10.1
9.0
17
17
D73.1
ICD-10 Finland
Hypersplenism
36.9
9.0
11
*
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
3.2
9.0
46
148
M48.0
ICD-10 Finland
Spinal stenosis
1.8
9.0
149
850
SPAT1263
SPAT
Sampling
1.4
9.0
627
5044
G81.9
ICD-10 Finland
Hemiplegia, unspecified
5.1
9.0
27
54
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
1.8
8.9
154
891
L01AA02
ATC
chlorambucil; oral
18.7
8.9
13
7
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
4.4
8.9
31
72
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.7
8.9
208
1317
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.7
8.9
171
1023
K59.09
ICD-10 Finland
Constipation, unspecified
2.2
8.9
92
438
H02AB02
ATC
dexamethasone; systemic
1.8
8.9
152
879
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.9
8.9
124
668
J04AB02
ATC
rifampicin; systemic
4.5
8.9
30
68
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
8.0
8.9
19
24
G93.3
ICD-10 Finland
Postviral fatigue syndrome
8.0
8.9
19
24
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
4.0
8.8
34
87
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
3.7
8.8
37
102
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.5
8.8
373
2727
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
10.8
8.8
16
15
J41.1
ICD-10 Finland
Mucopurulent chronic bronchitis
10.8
8.8
16
15
D02AE01
ATC
carbamide; topical
2.0
8.8
109
561
JAH01
NOMESCO Finland
Laparoscopy
2.3
8.8
78
345
L20.0
ICD-10 Finland
Besnier prurigo
1.9
8.8
123
663
ZZR00
NOMESCO Finland
Flap of skin
3.6
8.8
38
108
137
Kela drug reimbursment
Uraemia requiring dialysis
6.0
8.8
23
39
WX730
NOMESCO Finland
Conventional respirator
3.9
8.7
34
88
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
3.9
8.7
34
88
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
4.4
8.7
30
69
WX720
NOMESCO Finland
Own respiration
2.5
8.7
64
259
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.7
8.7
179
1095
PJA10
NOMESCO Finland
Exploration of lymph nodes
4.9
8.7
27
56
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.0
8.7
106
542
JAH00
NOMESCO Finland
Laparotomy
2.9
8.7
50
174
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.2
8.7
90
429
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
4.7
8.6
28
61
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.0
8.6
49
168
B07.9
ICD-10 Finland
Verruca simplex
2.7
8.6
58
222
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
16.4
8.6
13
8
K50.8
ICD-10 Finland
Other Crohn disease
3.7
8.5
36
100
J00
ICD-10 Finland
Acute nasopharyngitis [common cold]
3.1
8.5
44
143
L29.9
ICD-10 Finland
Pruritus, unspecified
3.2
8.5
42
132
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
10.1
8.5
16
16
J01XX08
ATC
linezolid; systemic
6.4
8.5
21
33
L04AA05
ATC
[U] tacrolimus; systemic
27.7
8.5
11
*
GBB00
NOMESCO Finland
Tracheostomy
5.2
8.5
25
49
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.9
8.5
115
614
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
7.4
8.4
19
26
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.1
8.4
96
478
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.3
8.4
74
328
R4190
NOMESCO Finland
Nutritional therapy
2.3
8.4
74
328
XCK00
NOMESCO Finland
Perimetry
2.1
8.4
98
492
R01AD11
ATC
triamcinolone; nasal
1.8
8.4
134
757
304
Kela drug reimbursment
Dornase alfa
90.5
8.4
9
*
R05CB13
ATC
dornase alfa (desoxyribonuclease); inhalant
90.5
8.4
9
*
C09AA02
ATC
enalapril; systemic
1.6
8.4
239
1597
M54.2
ICD-10 Finland
Cervicalgia
2.0
8.4
104
535
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
3.5
8.4
37
107
M03BC01
ATC
orphenadrine (citrate); systemic
1.5
8.4
344
2498
R05FB02
ATC
cough suppressants and expectorants
1.4
8.4
529
4168
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.9
8.4
48
166
RS222
NOMESCO Finland
NA
4.5
8.4
28
63
SXC03
NOMESCO Finland
Other oral or dental procedure
4.5
8.4
28
63
ZXX03
NOMESCO Finland
Extent of procedure, 3 units
7.9
8.4
18
23
DHB50
NOMESCO Finland
Turbinoplasty
2.8
8.3
53
196
L01EL01
ATC
ibrutinib; oral
+∞
8.3
8
*
D83.2
ICD-10 Finland
Common variable immunodeficiency with autoantibodies to B- or T-cells
+∞
8.3
8
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.0
8.3
101
515
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.5
8.3
37
108
N17.8
ICD-10 Finland
Other acute renal failure
5.5
8.3
23
42
J02AC03
ATC
voriconazole; systemic
10.8
8.3
15
14
A04
ICPC
Weakness/tiredness general
1.7
8.3
183
1141
SPAT1254
SPAT
Administration of medicine
1.6
8.3
202
1297
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.2
8.3
83
391
R01BA01
ATC
phenylpropanolamine; oral
2.1
8.3
88
426
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
2.9
8.3
48
168
WX725
NOMESCO Finland
Noninvasive ventilation
2.3
8.3
76
345
S01AA01
ATC
chloramphenicol; ophthalmic (antibiotics)
2.3
8.3
76
345
A03FA02
ATC
cisapride; oral, rectal
1.9
8.3
117
632
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
4.0
8.3
31
78
ZX100
NOMESCO Finland
Oral
4.0
8.3
31
78
M01AH02
ATC
rofecoxib; oral
1.7
8.2
178
1104
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
3.8
8.2
33
88
C01AA05
ATC
digoxin; systemic
2.2
8.2
83
393
H92.0
ICD-10 Finland
Otalgia
2.1
8.2
90
442
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.4
8.2
66
279
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.1
8.2
89
432
M87.0
ICD-10 Finland
Idiopathic aseptic necrosis of bone
7.6
8.2
18
24
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
2.1
8.1
85
409
SBA00
NOMESCO Finland
Microbiological examinations
2.8
8.1
49
177
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.8
8.1
147
865
R96
ICPC
Asthma
1.8
8.1
131
744
103
Kela drug reimbursment
Diabetes, insulin-treated
1.5
8.1
334
2424
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
4.2
8.1
29
70
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.8
8.1
51
187
D89.9
ICD-10 Finland
Disorder involving the immune mechanism, unspecified
33.5
8.1
10
*
M35.2
ICD-10 Finland
Behçet disease
33.5
8.1
10
*
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
33.5
8.1
10
*
J96.1
ICD-10 Finland
Chronic respiratory failure
3.6
8.1
35
100
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
17.3
8.1
12
7
M31.1
ICD-10 Finland
Thrombotic microangiopathy
17.3
8.1
12
7
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
9.0
8.0
16
18
ZZA00
NOMESCO Finland
Split skin graft
2.9
8.0
46
159
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
4.3
8.0
28
66
4AA24
NOMESCO Finland
NA
22.1
8.0
11
5
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
6.3
8.0
20
32
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.9
8.0
111
595
R49.01
ICD-10 Finland
Functional dysphonia
2.7
8.0
53
203
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
4.6
8.0
26
57
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.7
8.0
182
1147
XG405
NOMESCO Finland
Education on PEF monitoring
4.1
8.0
29
71
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.1
8.0
90
447
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
2.3
7.9
70
310
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.9
7.9
105
556
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.9
7.9
107
571
E000003
ATC
NA
2.2
7.9
75
343
N02AC04
ATC
dextropropoxyphene; oral
2.6
7.9
55
216
B99
ICPC
Blood/lymph/spleen disease other
7.8
7.9
17
22
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
3.8
7.9
31
82
R01AC01
ATC
cromoglicic acid; nasal
2.3
7.8
67
293
Z49.2
ICD-10 Finland
Other dialysis
6.1
7.8
20
33
H25.1
ICD-10 Finland
Senile nuclear cataract
1.5
7.8
264
1835
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
2.8
7.8
48
176
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.6
7.8
227
1524
L50.8
ICD-10 Finland
Other urticaria
3.4
7.8
35
103
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.6
7.8
194
1252
M87.9
ICD-10 Finland
Osteonecrosis, unspecified
10.8
7.8
14
13
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
4.9
7.8
24
50
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
3.9
7.8
30
78
A99
ICPC
Disease/condition unspecnature/site
1.9
7.7
111
604
DFF00
NOMESCO Finland
Pure tone audiometry
1.8
7.7
119
666
K51.8
ICD-10 Finland
Other ulcerative colitis
4.3
7.7
27
64
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
7.7
341
2511
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.5
7.7
307
2213
GD2SN
NOMESCO Finland
Lung ventilation SPECT
7.5
7.7
17
23
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
3.2
7.7
38
121
B01AC04
ATC
clopidogrel; oral
1.7
7.7
169
1053
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
7.7
235
1595
L95
ICPC
Osteoporosis
2.8
7.6
46
167
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.6
7.6
213
1415
RS230
NOMESCO Finland
NA
8.1
7.6
16
20
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
4.9
7.6
23
47
TQW40
NOMESCO Finland
Remowal of suture of skin
1.9
7.6
104
558
GD1BG
NOMESCO Finland
MRI of lungs and pleura with high intensity magnet
25.1
7.6
10
*
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
3.6
7.6
32
90
M54.5
ICD-10 Finland
Low back pain
1.4
7.6
460
3586
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
3.9
7.6
29
75
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
2.3
7.6
68
306
S29
ICPC
Skin symptom/complaint other
1.6
7.5
231
1567
A12BA01
ATC
potassium chloride; oral
2.6
7.5
53
210
TEA00
NOMESCO Finland
Biopsy of lip
5.4
7.5
21
39
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
4.3
7.5
26
61
H57.1
ICD-10 Finland
Ocular pain
2.6
7.5
52
203
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.5
7.5
242
1661
A09AA02
ATC
multienzymes (lipase, protease etc.)
3.3
7.5
36
112
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.0
7.5
91
466
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
4.1
7.5
27
66
M79.1
ICD-10 Finland
Myalgia
1.6
7.5
188
1217
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.6
7.5
186
1198
R04
ICPC
Breathing problem other
2.5
7.5
56
230
D50.8
ICD-10 Finland
Other iron deficiency anaemias
4.0
7.5
28
71
C09CA06
ATC
candesartan; oral
1.5
7.5
284
2022
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.9
7.5
105
568
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
7.5
801
6839
D07BC01
ATC
betamethasone and antiseptics; topical
1.7
7.4
167
1047
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
2.4
7.4
59
250
D01
ICPC
Abdominal pain/cramps general
1.7
7.4
162
1006
I01.0
ICD-10 Finland
Acute rheumatic pericarditis
80.4
7.4
8
*
W22
ICD-10 Finland
Striking against or struck by other object(s)
2.0
7.4
95
498
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
2.6
7.4
52
206
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
2.9
7.4
43
152
B01AF02
ATC
apixaban; oral
1.9
7.4
106
577
R51.81
ICD-10 Finland
Facial pain NOS
3.0
7.4
40
136
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.2
7.4
72
337
E87.5
ICD-10 Finland
Hyperkalaemia
3.8
7.4
29
77
QBA10
NOMESCO Finland
Incision of skin of trunk
4.7
7.3
23
49
H53.1
ICD-10 Finland
Subjective visual disturbances
2.0
7.3
87
440
M01AG02
ATC
tolfenamic acid; oral, rectal
1.5
7.3
220
1490
Z29.1
ICD-10 Finland
Prophylactic immunotherapy
+∞
7.3
7
*
27510
ICD-8 Finland
Plasma protein abnormalities, Hypogammaglobulinaemia
+∞
7.3
7
*
D82.0
ICD-10 Finland
Wiskott-Aldrich syndrome
+∞
7.3
7
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
9.4
7.3
14
15
R03AC19
ATC
olodaterol; inhalant
9.4
7.3
14
15
R62.0
ICD-10 Finland
Delayed milestone
4.9
7.3
22
45
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.1
7.3
83
415
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.1
7.3
81
402
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
6.3
7.2
18
29
GX1K5
NOMESCO Finland
Diffusion capacity
15.8
7.2
11
7
1CX01
NOMESCO Finland
NA
15.8
7.2
11
7
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
15.8
7.2
11
7
B03BA03
ATC
hydroxocobalamin; parenteral
2.1
7.2
78
382
J35.0
ICD-10 Finland
Chronic tonsillitis
2.0
7.2
87
446
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
4.0
7.2
27
69
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.5
7.2
53
214
D59.9
ICD-10 Finland
Acquired haemolytic anaemia, unspecified
30.1
7.1
9
*
N18.8
ICD-10 Finland
Other chronic renal failure
2.8
7.1
42
150
GDA10
NOMESCO Finland
Biopsy of lung
20.1
7.1
10
5
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
20.1
7.1
10
5
N06AB10
ATC
escitalopram; oral
1.5
7.1
284
2042
R35
ICD-10 Finland
Polyuria
2.0
7.1
86
439
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.2
7.1
72
340
H20.1
ICD-10 Finland
Chronic iridocyclitis
4.2
7.1
25
60
M01AE02
ATC
naproxen; oral, rectal
1.3
7.1
846
7315
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.0
7.1
92
483
205
Kela drug reimbursment
Chronic hypertension
1.4
7.1
315
2315
J01DC04
ATC
cefaclor; oral
3.6
7.1
30
85
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
4.0
7.1
26
65
N07BC02
ATC
methadone; systemic
12.1
7.1
12
10
NH1AD
NOMESCO Finland
Ankle and foot CT
3.1
7.1
37
123
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
3.3
7.1
33
101
NHG20
NOMESCO Finland
Fusion of talocrural joint
8.8
7.0
14
16
LWE00
NOMESCO Finland
Reoperation for deep haemorrhage in gynaecological surgery
8.8
7.0
14
16
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.0
7.0
90
472
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
4.7
7.0
22
47
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.7
7.0
147
905
I20.00
ICD-10 Finland
Unstable angina
2.9
7.0
41
146
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.7
7.0
147
907
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
3.6
7.0
29
81
1300
FHL
Esophagogastroduodenoscopy (also includes staining)
4.9
7.0
21
43
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
4.9
7.0
21
43
T99
ICPC
Endocr/metab/nutrit disease other
3.8
7.0
27
71
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
2.2
7.0
71
337
R09
ICPC
Sinus symptom/complaint
1.8
7.0
114
651
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
2.7
7.0
45
170
D02AX
ATC
Other emollients and protectives
2.2
6.9
64
292
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
2.9
6.9
40
140
J01MA06
ATC
norfloxacin; oral
1.6
6.9
182
1188
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
6.3
6.9
17
27
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
6.3
6.9
17
27
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
5.2
6.9
20
39
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
5.2
6.9
20
39
R06.5
ICD-10 Finland
Mouth breathing
1.8
6.9
121
706
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.1
6.9
76
375
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.1
6.9
76
375
TK810
NOMESCO Finland
Hemofiltration
5.9
6.9
18
31
RS121
NOMESCO Finland
NA
5.9
6.9
18
31
M81.8
ICD-10 Finland
Other osteoporosis
5.9
6.9
18
31
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
4.1
6.9
25
62
L95.8
ICD-10 Finland
Other vasculitis limited to skin
13.8
6.9
11
8
NK6PA
NOMESCO Finland
Measurement of bone density from one location with X-ray
13.8
6.9
11
8
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.5
6.9
52
215
TQW11
NOMESCO Finland
Vacuum treatment of wound
3.3
6.9
32
98
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
3.8
6.9
27
72
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
3.2
6.9
34
109
ZXD35
NOMESCO Finland
Usual procedure
2.5
6.8
52
216
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
4.8
6.8
21
44
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
3.4
6.8
31
93
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.5
6.8
237
1653
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
6.8
576
4723
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
8.3
6.8
14
17
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
8.3
6.8
14
17
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
2.9
6.8
39
135
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
6.7
6.8
16
24
JMA10
NOMESCO Finland
Transabdominal total splenectomy
6.7
6.8
16
24
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
6.7
6.8
16
24
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
4.2
6.8
24
58
XF404
NOMESCO Finland
Ambulatory ECG
1.7
6.8
132
796
F45.8
ICD-10 Finland
Other somatoform disorders
1.8
6.8
105
586
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
3.5
6.8
29
83
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
2.9
6.8
39
136
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.8
6.8
41
150
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
4.5
6.8
22
49
R60.1
ICD-10 Finland
Generalized oedema
6.1
6.8
17
28
UJF02
NOMESCO Finland
Peroral enteroscopy
6.1
6.8
17
28
B01.9
ICD-10 Finland
Varicella without complication
5.7
6.8
18
32
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
40.2
6.8
8
*
L01XX52
ATC
venetoclax; oral
40.2
6.8
8
*
JAK03
NOMESCO Finland
Laparotomy and peritoneal irrigation
16.8
6.7
10
6
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
3.4
6.7
30
89
GD1UN
NOMESCO Finland
Lung circulation SPECT
7.2
6.7
15
21
SHA04
NOMESCO Finland
Correction of physiology of bite - very demanding therapy visit
3.9
6.7
25
64
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.8
6.7
108
615
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
3.3
6.7
31
95
R28
ICPC
Limited function/disability (R)
4.9
6.7
20
41
C08CA13
ATC
lercanidipine; oral
1.7
6.7
150
942
J30.0
ICD-10 Finland
Vasomotor rhinitis
2.7
6.7
41
152
EMB30
NOMESCO Finland
Adenotomy
2.5
6.6
48
195
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
3.1
6.6
34
112
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
5.5
6.6
18
33
L57.0
ICD-10 Finland
Actinic keratosis
1.8
6.6
109
624
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
2.8
6.6
39
141
PEH57
NOMESCO Finland
Bypass from femoral artery to popliteal artery below knee
8.7
6.6
13
15
L82
ICD-10 Finland
Seborrhoeic keratosis
1.6
6.5
190
1275
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
2.6
6.5
46
182
N06AX05
ATC
trazodone; oral
2.7
6.5
42
157
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
4.8
6.5
20
42
FM1LE
NOMESCO Finland
Combined ultrasound and EKG examination of heart with tolerance test
10.1
6.5
12
12
B01AB10
ATC
tinzaparin; parenteral
1.9
6.5
94
516
L12
ICPC
Hand/finger symptom/complaint
1.5
6.5
195
1316
K20
ICD-10 Finland
Oesophagitis
3.7
6.5
26
71
NHQ40
NOMESCO Finland
Amputation of toe
3.8
6.5
25
66
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.3
6.5
55
241
QDA10
NOMESCO Finland
Incision of skin of lower limb
5.3
6.5
18
34
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
5.3
6.5
18
34
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.5
6.5
199
1353
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.6
6.5
43
167
M02AA07
ATC
piroxicam; topical
1.3
6.4
473
3792
Z00.0
ICD-10 Finland
General medical examination
1.5
6.4
246
1752
J20.6
ICD-10 Finland
Acute bronchitis due to rhinovirus
70.1
6.4
7
*
L01XX47
ATC
[U] idelalisib; oral
70.1
6.4
7
*
187
Kela drug reimbursment
MPA
70.1
6.4
7
*
372
Kela drug reimbursment
Idelalisib
70.1
6.4
7
*
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
7.4
6.4
14
19
S70.0
ICD-10 Finland
Contusion of hip
2.5
6.4
47
193
WX704
NOMESCO Finland
Intubation
1.8
6.4
102
578
GDG10
NOMESCO Finland
Bilateral transplantation of lung
14.4
6.4
10
7
RJ414
NOMESCO Finland
NA
14.4
6.4
10
7
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
4.1
6.4
23
57
K57.2
ICD-10 Finland
Diverticular disease of large intestine with perforation and abscess
3.3
6.4
30
93
A10BH05
ATC
linagliptin; oral
2.3
6.3
57
257
A03CA02
ATC
clidinium and psycholeptics; oral
2.0
6.3
78
403
R51
ICD-10 Finland
Headache
2.0
6.3
80
417
L27.1
ICD-10 Finland
Localized skin eruption due to drugs and medicaments
6.6
6.3
15
23
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
8.2
6.3
13
16
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
2.8
6.3
38
139
A87.9
ICD-10 Finland
Viral meningitis, unspecified
5.2
6.3
18
35
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
5.2
6.3
18
35
SBB10
NOMESCO Finland
Teeth copy
1.7
6.3
114
674
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
3.5
6.3
27
78
49302
ICD-8 Finland
Asthma, Rhinitis allergica cum asthmate bronchiali
6.0
6.3
16
27
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.0
6.3
78
405
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
11.1
6.3
11
10
R5110
SPAT
NA
2.8
6.3
37
133
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
2.1
6.3
64
305
H65.4
ICD-10 Finland
Other chronic nonsuppurative otitis media
9.3
6.3
12
13
A08
ICPC
Swelling
2.3
6.3
55
247
E66.9
ICD-10 Finland
Obesity, unspecified
2.2
6.3
59
271
ZZH31
NOMESCO Finland
Bone allograft, small pieces
4.6
6.3
20
44
R20.2
ICD-10 Finland
Paraesthesia of skin
1.8
6.3
95
528
A29
ICPC
General symptom/complaint other
1.6
6.3
146
927
D84.14
ICD-10 Finland
C1 esterase inhibitor deficiency (C1-INH deficiency)
+∞
6.3
6
*
D81.6
ICD-10 Finland
Major histocompatibility complex class I deficiency
+∞
6.3
6
*
4AA17
NOMESCO Finland
NA
+∞
6.3
6
*
J20.4
ICD-10 Finland
Acute bronchitis due to parainfluenza virus
+∞
6.3
6
*
M54.6
ICD-10 Finland
Pain in thoracic spine
1.8
6.3
97
545
S92.3
ICD-10 Finland
Fracture of metatarsal bone
2.4
6.2
48
201
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.5
6.2
237
1688
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
4.3
6.2
21
49
D89.80
ICD-10 Finland
Immunoglobulin A (IgA) deposits in organisms
26.8
6.2
8
*
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
26.8
6.2
8
*
J15.1
ICD-10 Finland
Pneumonia due to Pseudomonas
26.8
6.2
8
*
399
Kela drug reimbursment
Venetoclax
26.8
6.2
8
*
M54.4
ICD-10 Finland
Lumbago with sciatica
1.5
6.2
216
1508
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.2
6.2
61
286
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.8
6.2
93
517
N02CC06
ATC
eletriptan; oral
2.3
6.2
53
232
E66.01
ICD-10 Finland
Obesity due to excess calories
1.7
6.2
113
670
D68.8
ICD-10 Finland
Other specified coagulation defects
4.1
6.2
22
54
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
4.1
6.2
22
54
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
3.6
6.2
26
74
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.7
6.2
118
709
J37.0
ICD-10 Finland
Chronic laryngitis
2.4
6.2
50
213
F45.0
ICD-10 Finland
Somatization disorder
6.3
6.2
15
24
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
5.4
6.2
17
32
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.7
6.1
38
142
B00.9
ICD-10 Finland
Herpesviral infection, unspecified
5.8
6.1
16
28
R06.4
ICD-10 Finland
Hyperventilation
3.4
6.1
27
80
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
3.4
6.1
27
80
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.0
6.1
74
378
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
2.5
6.1
44
178
R50.0
ICD-10 Finland
Fever with chills
7.7
6.1
13
17
UGC02
NOMESCO Finland
Rigid bronchoscopy
7.7
6.1
13
17
N05BA06
ATC
lorazepam; systemic, sublingual
2.0
6.1
70
352
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.7
6.1
112
665
F43.21
ICD-10 Finland
Adaptation disorder with prolonged depression
4.7
6.1
19
41
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
4.7
6.1
19
41
D06BB03
ATC
aciclovir; topical
2.0
6.1
68
340
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
2.3
6.1
50
217
B37.8
ICD-10 Finland
Candidiasis of other sites
12.6
6.1
10
8
N30.9
ICD-10 Finland
Cystitis, unspecified
1.9
6.1
78
410
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
8.6
6.1
12
14
C01DA14
ATC
isosorbide mononitrate; oral
1.6
6.0
150
966
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
4.9
6.0
18
37
D86.1
ICD-10 Finland
Sarcoidosis of lymph nodes
4.9
6.0
18
37
K56.0
ICD-10 Finland
Paralytic ileus
4.9
6.0
18
37
TNX99
NOMESCO Finland
Other orthopaedic minor procedure
2.5
6.0
43
172
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
3.4
6.0
27
81
D69.9
ICD-10 Finland
Haemorrhagic condition, unspecified
6.7
6.0
14
21
PEH56
NOMESCO Finland
Bypass from femoral to popliteal artery above knee
6.7
6.0
14
21
E23.03
ICD-10 Finland
Lack of ACTH
10.1
6.0
11
11
J34.2
ICD-10 Finland
Deviated nasal septum
2.0
6.0
72
370
N03AF02
ATC
oxcarbazepine; oral
2.3
6.0
52
230
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
3.5
6.0
26
76
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3005322) IgE [Units/volume] in Serum or Plasma
558
1032
7.35
307.72
1.9
1.2
u/ml
218.8
211.0
0.05
464
949
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
254
115
25.50
307.65
2.5
2.2
e6/l
750.5
785.6
0.13
64
41
(3011412) CD3 cells [#/volume] in Blood
420
138
39.23
307.65
2.8
2.4
e9/l
1.4
1.3
0.23
315
80
(3000060) B lymphocytes [#/volume] in Blood
221
57
43.98
307.65
2.5
3.0
e6/l
494.4
285.5
0.58
160
31
(3005719) IgG [Mass/volume] in Serum or Plasma
882
1121
14.29
307.65
10.7
2.5
g/l
8.7
10.4
17.71
860
1029
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
368
106
43.23
307.65
2.7
2.5
%
12.6
10.4
1.35
245
62
(3028192) IgG subclass 2 [Mass/volume] in Serum
351
140
30.80
307.65
2.0
1.3
g/l
2.0
2.8
4.57
282
97
(4062490)
358
143
30.90
307.65
2.1
1.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
749
890
13.58
307.65
4.2
1.7
g/l
1.1
1.4
1.55
679
824
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
318
104
36.82
307.65
2.8
2.4
e9/l
0.2
0.2
0.57
275
87
(3024980) IgG subclass 4 [Mass/volume] in Serum
374
237
19.59
307.65
2.0
1.6
g/l
0.4
0.9
4.60
293
181
(3024139) IgG subclass 3 [Mass/volume] in Serum
350
140
30.69
307.65
2.0
1.3
g/l
0.3
0.4
3.02
283
97
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
380
103
46.33
307.65
2.8
2.5
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
350
140
30.69
307.65
2.0
1.3
g/l
5.1
7.1
5.17
284
97
(21494815) CD4 cells/100 lymphocytes in Specimen
324
124
31.55
307.65
2.6
2.4
%
36.7
46.9
1.34
23
14
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
322
107
36.33
307.65
2.8
2.4
e6/l
580.2
595.8
0.06
274
88
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
357
453
9.55
272.10
2.1
1.6
g/l
0.2
0.2
2.08
320
427
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
359
468
9.30
267.62
2.1
1.6
g/l
1.2
1.2
0.52
333
439
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
156
37
46.01
263.25
1.2
1.1
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
167
68
26.93
239.93
2.2
2.4
umol/l
2.0
1.9
0.37
158
62
(3007164) IgA [Mass/volume] in Serum or Plasma
902
3196
4.60
227.01
3.8
1.5
g/l
1.5
2.3
31.54
665
1921
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
289
387
8.68
208.93
3.0
2.1
mg/l
11.2
11.6
0.41
281
351
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
242
289
9.50
191.34
6.8
6.0
iu/ml
800.5
282.4
0.58
41
39
(3023419) Bacteria identified in Sputum by Culture
192
165
12.89
191.11
4.5
2.8
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
118
44
28.60
174.25
2.5
2.0
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
1381
7559
4.40
172.36
16.9
5.9
e9/l
0.6
0.6
0.67
1309
6522
(3006315) Basophils [#/volume] in Blood
1382
7585
4.39
171.38
16.9
6.0
e9/l
0.0
0.0
2.03
1309
6548
(42870588) Differential panel, method unspecified - Blood
1087
5092
3.81
170.72
15.8
6.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
144
93
16.72
168.40
2.9
2.6
%
38.5
45.4
1.45
59
26
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
204
230
9.86
168.06
4.1
3.9
u/ml
5862.6
1828.9
0.54
19
15
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
108
36
31.82
165.34
2.6
2.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
238
336
8.00
163.37
2.5
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
236
330
8.07
163.34
2.5
1.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
1388
7794
4.26
162.67
17.0
6.0
e9/l
2.0
2.0
0.01
1328
6865
(3013115) Eosinophils [#/volume] in Blood
1391
7848
4.25
161.25
17.6
6.3
e9/l
0.2
0.2
0.21
1329
6887
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
399
973
4.97
155.59
2.9
1.6
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
153
7
238.35
150.52
1.4
1.1
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
1264
6903
3.70
148.76
17.5
6.2
%
0.6
0.7
1.21
1241
6452
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
245
400
6.92
146.91
3.4
2.6
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
1288
7158
3.72
146.55
18.2
6.4
%
8.6
8.5
1.36
1263
6718
(3006504) Eosinophils/100 leukocytes in Blood
1282
7114
3.70
145.97
17.7
6.1
%
2.7
2.9
1.18
1255
6641
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
467
1356
4.28
144.92
3.9
2.5
g/l
0.2
0.2
4.27
444
1277
(3018010) Neutrophils/100 leukocytes in Blood
1292
7284
3.65
141.64
16.6
5.9
%
57.4
56.4
1.81
1265
6832
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
610
2166
3.73
141.60
3.2
1.8
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
1299
7385
3.63
139.67
17.7
6.1
%
28.4
28.9
0.78
1273
6905
(3013650) Neutrophils [#/volume] in Blood by Automated count
1434
8757
3.98
136.12
22.3
9.0
e9/l
4.1
4.0
0.23
1367
7642
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
136
6
244.70
133.89
1.5
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
824
3649
3.29
132.83
8.5
4.2
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
477
1519
3.90
128.73
7.6
4.2
u/l
234.2
251.9
1.44
468
1442
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
177
239
8.09
125.52
2.1
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
178
242
8.04
125.50
2.4
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
559
2029
3.53
123.24
3.1
2.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
463
1509
3.77
119.99
2.7
1.7
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
115
104
11.73
109.98
1.9
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
450
1522
3.60
109.34
2.9
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
478
1716
3.42
105.38
2.7
1.7
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
359
1091
3.85
101.79
3.8
2.8
g/l
63.7
66.7
8.40
346
996
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
139
181
8.23
101.31
2.1
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
143
194
7.91
100.66
2.3
1.6
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
552
2228
3.12
99.36
3.9
2.4
umol/l
12.3
13.5
3.08
530
2060
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
125
148
8.99
98.38
3.6
1.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
519
2035
3.17
98.05
3.9
2.4
g/l
2.4
2.4
0.14
496
1887
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
493
1881
3.22
97.51
4.0
2.5
%
21.2
23.2
2.17
444
1626
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
133
175
8.12
96.03
3.5
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
193
376
5.62
95.60
1.7
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1104
6512
2.76
95.38
14.9
6.3
mmol/l
1.2
1.2
1.95
1040
5917
(3002179) Metamyelocytes/100 leukocytes in Blood
349
1092
3.72
94.34
7.7
4.1
%
0.5
0.6
0.32
125
254
(3017181) Myelocytes/100 leukocytes in Blood
367
1202
3.57
92.45
8.3
4.2
%
0.9
0.9
0.03
153
351
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
130
178
7.79
90.66
2.3
1.4
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
58
18
33.25
90.23
1.7
2.3
ug/g
192.2
146.9
0.79
48
18
(40758558) Short blood count panel - Blood
774
3906
2.70
90.09
14.7
6.6
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
493
1970
3.06
89.12
12.0
5.9
mmol/l
1.1
1.1
0.02
476
1833
(3024561) Albumin [Mass/volume] in Serum or Plasma
1037
6071
2.64
88.59
10.1
4.8
g/l
34.8
35.9
7.23
998
5653
(3000494) Fungus identified in Specimen by Culture
452
1724
3.16
88.55
2.4
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
303
897
3.85
88.51
3.7
2.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
139
211
7.05
88.35
2.3
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1159
7174
2.69
88.06
15.5
6.8
mmol/l
1.2
1.2
1.14
1006
6094
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
101
105
10.12
87.57
3.0
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
223
530
4.65
87.43
2.8
1.7
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
101
106
10.03
86.97
3.0
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
419
1547
3.22
86.57
5.7
3.0
%
2.0
1.8
2.39
394
1396
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1185
7469
2.67
85.83
11.0
6.2
umol/l
10.4
11.6
3.10
1148
7069
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1046
6229
2.59
84.98
4.0
2.3
nmol/l
80.1
76.4
3.95
986
5632
(44790047)
122
170
7.62
83.72
2.1
1.6
—
—
—
0
0
(44790048)
122
170
7.62
83.72
2.1
1.6
—
—
—
0
0
(44806118)
122
170
7.62
83.72
2.1
1.6
—
—
—
0
0
(44790049)
122
170
7.62
83.72
2.1
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
148
261
6.08
81.19
1.8
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
114
154
7.83
80.33
2.2
1.7
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
491
2063
2.89
80.03
1.8
1.3
titre
465.1
525.4
0.41
102
427
(3023520) Reticulocytes [#/volume] in Blood
335
1128
3.41
80.03
4.8
3.0
e9/l
79.0
71.3
2.30
263
836
(3021440) Promyelocytes/100 leukocytes in Blood
336
1141
3.38
79.13
8.7
4.3
%
0.1
0.1
0.08
145
323
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
67
42
16.52
79.00
3.0
1.9
—
—
—
0
0
(3018418) pH of Serum or Plasma
779
4161
2.52
77.92
8.3
3.8
ph
7.4
7.4
0.14
162
778
(3028433) Virus identified in Specimen by Culture
73
55
13.78
77.90
2.0
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
321
1070
3.43
77.79
8.7
4.4
%
0.0
0.7
0.97
129
270
(3036481) Cortisol [Moles/volume] in Serum or Plasma
387
1449
3.12
77.33
3.3
2.1
nmol/l
327.9
369.2
3.62
362
1341
(3012095) Magnesium [Moles/volume] in Serum or Plasma
521
2297
2.77
77.15
8.7
3.8
mmol/l
0.8
0.8
2.55
494
2164
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1522
11233
3.14
75.38
17.9
7.2
u/l
82.8
80.0
1.69
1480
10583
(3009445) Proteinase 3 Ab [Units/volume] in Serum
223
599
4.10
74.14
1.8
1.4
u/ml
5.2
12.9
1.08
11
11
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
99
125
8.32
73.78
4.9
3.7
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
66
46
14.85
73.55
1.4
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
701
3675
2.47
71.70
3.6
2.2
mg/l
3.2
2.9
2.07
651
3126
(3021589) Normoblasts [#/volume] in Blood
1069
6755
2.41
71.58
22.2
9.2
e9/l
0.0
0.0
0.19
937
5473
(3013707) Erythrocyte sedimentation rate by Westergren method
1483
10972
2.88
69.52
10.6
4.0
mm/h
13.5
11.5
5.89
1432
10175
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
223
636
3.86
67.98
2.9
2.0
u/l
40.8
39.2
0.53
211
566
(3033658) Prothrombin time (PT) actual/Normal
698
3741
2.40
67.01
6.4
4.1
%
95.3
91.5
3.59
684
3637
(46235355) HIV 1 and 2 tests - Meaningful Use set
593
2962
2.48
66.48
2.1
1.9
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
332
1272
2.97
62.71
13.8
7.6
mmol/l
10.3
8.7
3.11
316
1219
(3037756) Immunofixation for Serum or Plasma
135
282
5.09
61.35
1.7
1.6
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
189
519
3.95
60.60
3.3
2.0
ug/l
1.5
1.8
0.15
177
458
(36304419) Bacteria [Presence] in Urine
697
3878
2.29
59.88
5.1
3.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
627
3339
2.34
59.71
11.5
4.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
183
501
3.95
58.88
4.5
2.3
g/l
7.2
7.3
0.51
135
395
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
183
501
3.95
58.88
4.5
2.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
183
501
3.95
58.88
4.5
2.3
g/l
3.5
3.7
0.60
132
377
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
177
475
4.02
58.55
4.5
2.4
g/l
3.0
3.1
0.34
132
385
(3042111) Morphology [Interpretation] in Bone marrow Narrative
115
217
5.59
58.52
1.9
1.7
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
64
62
10.66
58.15
2.2
1.2
g/l
0.3
0.3
1.09
45
50
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
87
125
7.26
57.92
2.5
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
87
125
7.26
57.92
2.5
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
87
125
7.26
57.92
2.5
1.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1206
8457
2.26
57.38
10.4
4.9
mmol/l
6.6
6.6
0.07
1162
7897
(3030467) Casts [#/volume] in Urine by Automated count
696
3949
2.23
56.24
5.3
3.1
e6/l
0.3
0.4
0.50
577
2955
(3026782) Osmolality of Urine
546
2804
2.35
55.96
4.8
2.7
mosm/kgh2o
514.2
546.9
3.07
503
2389
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
163
429
4.07
55.31
4.6
2.5
g/l
0.9
1.0
0.02
145
382
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
134
304
4.68
55.12
2.8
1.4
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
61
60
10.48
54.82
2.3
1.2
%
84.6
110.2
3.58
56
51
(3048689) Calprotectin [Mass/mass] in Stool
428
1989
2.50
54.65
3.1
2.5
ug/g
145.1
116.0
0.97
360
1575
(3018095) Leukocytes [#/volume] in Urine
833
5131
2.15
54.12
6.2
3.7
e6/l
109.9
103.2
0.06
646
3560
(3002582) Erythrocytes [#/volume] in Urine
732
4315
2.16
53.00
5.5
3.2
e6/l
35.9
88.1
1.46
609
3295
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1013
6766
2.12
52.69
4.8
2.8
ug/l
160.7
108.4
3.02
973
6289
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
172
487
3.80
52.62
1.8
1.5
titre
226.7
125.9
—
6
17
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
801
4903
2.13
52.44
5.4
3.3
u/l
34.0
32.7
0.23
777
4674
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
82
124
6.88
52.06
1.9
1.3
u/ml
0.6
0.8
0.17
51
53
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
646
3649
2.19
51.91
4.3
3.0
ng/l
1567.0
1226.2
0.86
576
3069
(3052851) Hemolysis interference index of Serum or Plasma
159
430
3.96
51.91
3.3
3.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
191
588
3.51
51.54
2.3
1.8
g/l
1.4
1.5
0.77
160
514
(3000850) Epithelial cells [#/volume] in Urine
560
2995
2.25
51.44
4.7
2.5
e6/l
4.2
6.6
5.66
518
2618
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
130
306
4.50
51.03
1.5
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
130
306
4.50
51.03
1.5
1.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
190
587
3.50
50.98
1.4
1.2
u/ml
1.6
0.8
0.35
26
48
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
234
822
3.12
50.93
1.9
1.5
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
147
386
4.05
49.96
4.4
2.3
g/l
0.0
0.0
0.20
136
357
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
149
400
3.97
49.10
2.1
1.8
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
370
1681
2.51
49.08
4.0
3.1
umol/l
6.5
7.7
0.72
325
1455
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
280
1113
2.79
48.63
5.1
4.0
ng/l
86.6
80.5
0.57
260
995
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
161
467
3.68
47.45
4.8
2.4
g/l
8.0
10.4
7.24
136
406
(3025941) Bacteria identified in Stool by Culture
232
845
3.00
47.27
1.7
1.2
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
440
2193
2.33
47.27
3.6
2.4
s
29.3
29.7
0.67
427
2128
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
125
303
4.36
47.22
8.3
3.6
%
57.3
57.0
0.08
125
303
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
133
340
4.14
46.83
2.4
1.7
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
104
220
4.95
46.45
5.0
3.2
%
1.1
1.5
0.43
96
181
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
130
330
4.16
46.20
1.6
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
385
1827
2.40
46.16
2.0
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
160
471
3.63
46.11
2.4
1.9
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
91
173
5.48
45.86
3.4
1.4
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
159
468
3.63
45.82
5.8
3.5
g/l
3.6
3.5
0.42
147
444
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
53
55
9.89
45.82
2.2
2.3
u/ml
118495.9
56201.6
—
8
8
(40760888) Immunoglobulin light chains.free panel - Serum
120
289
4.37
45.69
6.1
3.9
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
44
35
12.86
45.30
1.5
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
91
176
5.39
45.00
3.4
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
90
173
5.42
44.80
3.4
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
90
173
5.42
44.80
3.4
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
53
57
9.55
44.63
2.7
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
90
174
5.39
44.52
3.4
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
58
71
8.40
44.20
2.8
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
58
71
8.40
44.20
2.8
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
58
71
8.40
44.20
2.8
1.5
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1278
9648
2.08
43.87
7.5
4.3
e6/l
287.8
2041.3
1.70
16
135
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
52
56
9.53
43.74
2.7
1.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
52
56
9.53
43.74
2.7
1.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
55
65
8.69
43.10
1.5
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
89
176
5.26
42.92
3.4
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
57
71
8.25
42.82
2.9
1.5
—
—
—
0
0
(3015736) pH of Urine
846
5572
1.97
42.56
4.7
3.4
—
5.8
—
0
5
(3032080) INR in Blood by Coagulation assay
831
5450
1.96
42.24
12.4
8.3
inr
1.1
1.2
1.76
237
1578
(3045142) Bone marrow Pathology biopsy report
85
164
5.39
42.13
1.9
1.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
681
4179
2.00
41.87
3.1
2.1
u/l
148.2
247.6
2.16
646
3949
(3034860) Kappa light chains.free [Mass/volume] in Serum
138
392
3.73
41.86
6.3
3.7
mg/l
48.2
62.2
0.37
109
321
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
138
393
3.72
41.70
6.3
3.7
mg/l
27.2
40.1
0.84
109
323
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
32
16
20.34
41.64
1.6
1.6
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
309
1394
2.46
41.05
11.1
4.6
kpa
5.8
5.8
0.18
299
1346
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
460
2460
2.16
40.88
2.0
1.6
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
132
372
3.75
40.49
2.0
1.2
iu/ml
8.5
13.0
—
5
6
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
117
303
4.06
40.42
1.6
1.5
u/ml
87.4
108.2
1.73
34
55
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
134
383
3.70
40.26
6.4
3.7
ratio
2.0
1.6
0.23
13
37
(3014576) Chloride [Moles/volume] in Serum or Plasma
350
1683
2.34
40.23
12.9
7.3
mmol/l
103.9
104.3
0.66
340
1646
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
137
398
3.64
40.18
4.5
2.3
g/l
38.9
37.9
1.13
127
353
(3002032) Base excess in Venous blood by calculation
306
1388
2.45
40.11
11.1
4.6
mmol/l
1.7
1.8
0.08
253
1097
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
573
3351
2.03
39.98
2.7
1.8
mg/l
1.3
1.1
0.30
471
2518
(3037467) Urinalysis macro (dipstick) panel - Urine
1309
10128
2.03
39.79
7.6
4.2
—
—
—
0
0
(4010399)
247
1016
2.66
39.72
1.7
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
286
1266
2.49
39.49
16.3
9.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
147
458
3.40
38.71
1.3
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
137
410
3.53
38.40
6.5
3.9
u/ml
0.3
0.4
0.33
91
224
(3000492) Spirometry study
310
1441
2.39
38.36
2.6
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
141
436
3.42
37.56
1.5
1.4
ug/g
314.5
292.4
0.58
85
247
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
243
1019
2.60
37.48
9.6
4.6
mmol/l
1.5
1.7
0.26
188
753
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
52
69
7.73
37.04
2.8
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
74
142
5.39
36.88
1.5
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
248
1059
2.55
36.82
9.7
4.6
kpa
5.1
5.1
0.44
236
999
(3014111) Lactate [Moles/volume] in Serum or Plasma
272
1214
2.46
36.74
14.0
8.2
mmol/l
1.3
1.3
0.18
254
1161
(3006184) Hemoglobin [Mass/volume] in Capillary blood
113
306
3.87
36.67
2.6
2.4
g/l
130.7
130.4
0.02
59
234
(3009343) pH of Capillary blood
246
1051
2.55
36.46
9.7
4.6
ph
7.4
7.4
0.34
35
106
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
104
267
4.07
36.33
1.6
1.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
62
102
6.26
36.27
2.7
1.6
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
125
366
3.59
36.19
4.8
2.4
g/l
0.0
0.0
0.50
115
338
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
56
83
6.93
36.18
2.7
1.5
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
124
363
3.59
35.91
4.8
2.4
g/l
0.0
0.0
0.00
115
337
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
112
306
3.83
35.88
1.4
1.2
u/ml
2.9
5.4
0.31
17
23
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
51
69
7.58
35.73
2.8
1.6
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
41
42
9.96
35.72
5.8
4.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
33
24
13.98
35.70
2.0
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
59
94
6.45
35.61
1.5
1.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
699
4513
1.89
35.57
3.7
2.5
u/l
56.7
56.5
0.03
673
4177
(3044640) Blood type and Crossmatch panel - Blood
715
4654
1.88
35.44
4.0
2.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
830
5664
1.85
35.40
2.4
1.9
pmol/l
94.8
95.6
0.19
500
2953
(3021879) Hepatitis B virus core Ab [Presence] in Serum
263
1176
2.44
35.31
1.6
1.4
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
59
95
6.38
35.25
2.2
1.6
ug/l
12.7
7.1
0.46
54
81
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
43
48
9.15
35.18
1.6
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
323
1602
2.23
34.04
1.5
1.3
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
30
20
15.23
34.00
2.1
2.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
80
177
4.68
33.82
4.3
2.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
986
7163
1.82
33.68
5.7
3.5
estimate
0.0
0.0
0.00
217
1328
(3026493) Urate [Moles/volume] in Serum or Plasma
590
3666
1.90
33.34
5.6
2.6
umol/l
2975.9
5038.4
0.62
545
3212
(3009261) Glucose [Presence] in Urine by Test strip
995
7264
1.81
33.28
5.7
3.6
estimate
0.0
0.0
0.80
217
1304
(3021601) Nitrite [Presence] in Urine by Test strip
988
7199
1.81
33.25
7.3
4.9
estimate
0.0
0.0
0.50
220
1351
(3003396) Base excess in Arterial blood by calculation
308
1513
2.25
33.16
13.4
8.3
mmol/l
1.2
1.1
0.22
245
1165
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
80
181
4.58
32.91
9.8
6.1
mg/l
11.4
11.2
0.15
71
167
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
89
219
4.22
32.89
1.3
1.2
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
131
424
3.25
32.38
1.4
1.2
u/ml
10.4
33.2
0.92
16
22
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
153
543
2.98
32.31
4.2
3.3
%
98.0
91.6
2.48
146
512
(3030313) Adrenal Ab [Titer] in Serum
24
11
22.10
32.22
1.9
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
116
349
3.48
32.20
1.4
1.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
124
390
3.34
32.10
1.5
1.2
u/ml
1.8
2.8
0.75
19
36
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
43
54
8.13
32.06
1.6
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
194
786
2.64
31.90
2.3
1.6
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
280
1344
2.28
31.78
14.1
8.8
%
95.6
95.6
0.09
261
1296
(3048929) Epstein Barr virus Ab [Presence] in Serum
153
552
2.93
31.36
1.5
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
124
396
3.29
31.31
1.4
1.2
u/ml
8.3
9.9
0.08
28
63
(3024354) Oxygen [Partial pressure] in Venous blood
254
1178
2.34
31.22
11.4
4.3
kpa
4.9
4.8
0.54
247
1136
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
303
1516
2.20
31.04
13.6
8.3
kpa
5.1
5.1
0.00
282
1453
(3027801) Oxygen [Partial pressure] in Arterial blood
303
1517
2.20
30.99
13.6
8.2
kpa
11.8
12.5
1.54
282
1457
(3036489) Thrombin time
163
613
2.82
30.95
3.6
2.7
s
21.2
21.4
0.24
148
545
(3019309) Folate [Moles/volume] in Red Blood Cells
425
2418
1.99
30.85
1.9
1.7
nmol/l
1323.4
1184.5
1.99
345
1832
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
423
2405
1.99
30.76
3.6
2.7
e6/l
1.1
1.0
0.16
246
1343
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
404
2266
2.01
30.50
3.9
2.9
e6/l
2.5
2.5
0.08
229
1214
(3015377) Calcium [Moles/volume] in Serum or Plasma
720
4869
1.79
30.28
4.9
3.4
mmol/l
2.3
2.4
4.47
649
4284
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
26
17
15.50
29.71
1.2
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
88
232
3.93
29.63
1.5
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
54
95
5.83
29.52
2.1
1.3
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
114
360
3.31
29.30
4.1
3.3
mmol/l
24.2
24.7
0.59
106
319
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
139
494
2.96
29.25
4.2
1.7
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
30
26
11.71
29.19
1.4
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
198
847
2.50
29.02
9.7
5.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
108
332
3.39
28.97
1.5
1.3
u/ml
219.2
245.2
0.43
77
196
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
40
52
7.84
28.97
1.7
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
515
3183
1.86
28.85
1.9
1.5
nmol/l
21.3
20.8
0.24
467
2717
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
558
3543
1.83
28.61
3.7
2.3
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
46
71
6.62
28.61
34.1
31.2
ug/l
6.6
7.2
1.06
41
61
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
49
81
6.19
28.52
1.8
1.4
u/l
4.5
6.8
1.52
42
68
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
27
0
+∞
28.19
1.5
0.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
439
2610
1.90
27.59
4.7
3.5
ng/l
420.7
495.6
0.15
307
1890
(3007566) Smooth muscle Ab [Titer] in Serum
117
390
3.14
27.50
1.3
1.2
titre
77.1
99.3
0.40
14
28
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
129
459
2.95
27.07
2.9
2.2
ug/l
237.3
481.8
1.03
115
425
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
739
5176
1.72
26.52
5.3
3.4
ng/l
41.4
44.0
0.06
515
3323
(3037121) Protein [Mass/volume] in Urine
141
535
2.77
26.27
4.7
3.9
g/l
0.7
0.3
0.86
85
240
(3004119) Hemoglobin [Mass/volume] in Venous blood
185
804
2.45
26.13
10.9
4.0
g/l
125.1
128.3
1.08
180
782
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
130
474
2.88
26.09
1.7
1.6
iu/ml
0.8
0.1
0.73
39
83
(3026008) Bacteria identified in Urine by Culture
634
4273
1.74
26.02
4.4
2.9
—
—
—
0
0
(4035726)
252
1259
2.16
25.62
1.8
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
41
63
6.63
25.60
1.7
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
41
63
6.63
25.60
1.7
1.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
61
137
4.57
25.33
1.3
1.2
u/l
133.7
62.8
0.48
45
93
(40768797) Stomach Pathology biopsy report
357
2040
1.93
25.03
1.4
1.2
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
248
1243
2.15
24.98
14.9
8.9
g/l
117.6
121.2
1.81
236
1199
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
167
708
2.50
24.86
1.3
1.1
u/ml
100.5
2.3
—
12
8
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
919
6906
1.67
24.73
6.6
4.0
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
100
324
3.21
24.64
1.5
1.2
u/ml
19.1
47.3
1.26
24
29
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
124
459
2.83
24.19
1.4
1.3
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
211
1005
2.24
24.09
15.6
9.3
mmol/l
24.5
24.8
0.76
205
999
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
263
1368
2.08
23.99
2.9
2.5
u/l
32.8
73.9
0.62
232
1162
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
139
550
2.65
23.84
3.9
1.8
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
43
75
5.85
23.72
31.9
33.2
ug/l
102.4
127.6
1.47
36
66
(3027273) Bicarbonate [Moles/volume] in Venous blood
150
618
2.55
23.70
5.3
3.5
mmol/l
25.2
25.3
0.11
144
595
(3008757) Leukocyte morphology finding [Identifier] in Blood
68
176
3.97
23.50
5.7
3.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
212
1022
2.22
23.49
3.9
2.8
ng/l
179.5
175.0
0.05
191
928
(3051651) Icteric interference index of Serum or Plasma
51
106
4.92
23.24
3.6
3.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
516
3380
1.73
22.88
5.0
3.6
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
70
189
3.81
22.81
1.6
1.3
u/ml
29.7
50.1
—
10
8
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
121
457
2.76
22.72
1.2
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1674
15076
2.33
22.63
39.8
13.1
mg/l
21.3
22.6
1.03
1518
11736
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
181
831
2.31
22.51
14.6
5.2
mmol/l
24.0
24.0
0.06
163
769
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
35
53
6.71
22.16
1.6
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
35
53
6.71
22.16
1.6
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
88
283
3.22
21.96
5.7
3.8
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
36
58
6.31
21.49
1.1
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
80
249
3.31
21.05
1.1
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
55
135
4.17
20.43
1.3
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
173
815
2.24
20.20
14.1
7.5
mmol/l
24.9
24.4
0.83
159
760
(40761539) Cells [Type] in Urine sediment by Light microscopy
26
31
8.49
20.16
1.5
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
51
120
4.34
20.01
1.7
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
77
243
3.26
19.83
1.1
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
49
114
4.39
19.50
2.5
2.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
52
127
4.19
19.45
3.4
2.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
55
142
3.96
19.10
1.6
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
169
808
2.20
19.01
11.9
4.8
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
81
271
3.08
18.93
4.2
2.6
%
16.7
16.3
0.36
49
143
(3000093) Morphology [Interpretation] in Blood Narrative
52
130
4.09
18.86
1.3
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
75
241
3.20
18.76
4.0
3.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
58
158
3.76
18.69
3.5
3.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
31
50
6.29
18.49
1.5
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
785
5963
1.56
18.21
2.5
2.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
52
134
3.97
18.11
4.2
2.9
%
62.3
54.1
1.64
45
93
(3028626) Oxygen [Partial pressure] in Capillary blood
120
507
2.46
17.95
9.4
5.2
kpa
9.0
8.9
0.11
115
474
(4015189)
25
33
7.67
17.84
2.7
2.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
149
695
2.25
17.79
20.0
11.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
191
982
2.06
17.78
3.7
3.3
pmol/l
4.3
4.6
2.84
175
867
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
442
2951
1.66
17.54
1.8
1.6
pmol/l
27456393.3
33630178.9
0.11
397
2474
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
58
166
3.58
17.40
1.3
1.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
154
736
2.19
17.32
12.6
5.1
mmol/l
24.5
24.7
0.31
147
703
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
70
229
3.14
17.01
1.4
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
39
85
4.67
16.84
1.1
1.0
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
47
119
4.03
16.78
1.1
1.2
titre
250.0
108.4
—
6
19
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
247
1415
1.86
16.72
5.2
3.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
64
201
3.26
16.64
1.4
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1662
15236
2.02
16.46
38.1
14.7
mmol/l
139.4
139.7
5.02
1642
14845
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
57
168
3.47
16.37
4.1
2.4
pg
32.8
32.4
0.25
57
168
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
38
83
4.65
16.37
1.6
1.5
u/l
2.3
9.4
1.70
19
37
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
114
492
2.40
16.28
10.4
7.1
mg/l
1.6
1.4
1.44
108
459
(3020891) Body temperature
120
531
2.35
16.20
7.7
4.9
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
36
76
4.81
16.15
1.4
1.1
u/l
21.4
16.8
0.52
31
65
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
147
711
2.16
16.03
14.5
10.8
mmol/l
24.5
24.3
0.38
133
670
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
397
2633
1.65
15.99
1.4
1.3
iu/ml
26.1
31.2
0.35
131
820
(3003434) Protein [Mass/volume] in Pleural fluid
51
142
3.67
15.95
1.8
1.4
g/l
33.1
32.7
0.06
46
120
(3009508) Creatinine [Moles/volume] in Urine
601
4398
1.55
15.95
4.2
3.3
mmol/l
7.2
7.5
1.14
527
3740
(3009214) Lutropin [Units/volume] in Serum or Plasma
113
492
2.38
15.83
1.7
1.6
u/l
9.7
9.9
0.06
93
381
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
521
3707
1.57
15.61
1.4
1.3
u/ml
1.0
1.7
1.23
117
982
(3023103) Potassium [Moles/volume] in Serum or Plasma
1662
15282
1.98
15.61
38.8
14.8
mmol/l
3.9
4.0
0.81
1642
14863
(3004616) Nuclear Ab [Presence] in Serum
57
175
3.33
15.38
1.2
1.2
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
47
127
3.77
15.35
1.7
1.3
e6/l
1910.4
1700.8
0.15
37
80
(3009871) Measles virus Ab [Titer] in Serum
27
46
5.94
15.27
2.4
1.7
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
44
114
3.93
15.24
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
44
114
3.93
15.24
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
44
114
3.93
15.24
1.3
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
40
97
4.19
15.14
1.1
1.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
128
601
2.22
15.03
1.3
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
35
77
4.61
14.96
2.0
1.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
107
467
2.37
14.91
1.4
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
202
1126
1.89
14.83
9.4
3.7
mmol/l
1.2
1.2
0.53
190
970
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
78
295
2.72
14.64
1.3
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
43
113
3.87
14.62
1.3
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
43
113
3.87
14.62
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
43
113
3.87
14.62
1.3
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
106
465
2.36
14.61
1.4
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
107
474
2.34
14.42
1.4
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
76
286
2.73
14.41
6.6
4.3
mmol/l
2.3
2.5
0.31
57
194
(3029937) Albumin [Presence] in Urine by Test strip
527
3816
1.54
14.39
7.2
3.9
estimate
0.0
0.0
1.28
216
1316
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
70
253
2.84
14.32
5.0
3.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
713
5509
1.48
14.20
6.3
3.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
375
2518
1.62
14.19
1.4
1.2
u/ml
8.4
11.0
0.37
130
995
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
42
111
3.85
14.17
1.3
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
187
1032
1.90
14.14
3.1
2.9
e9/l
4.7
4.2
1.20
138
834
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
36
85
4.30
14.11
3.0
1.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
36
85
4.30
14.11
3.0
1.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1216
10451
1.49
13.89
4.3
3.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
45
127
3.61
13.83
1.7
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
90
376
2.47
13.82
2.0
1.7
mmol/l
3.7
3.7
0.26
82
356
(3028679) Herpes simplex virus Ab [Presence] in Serum
33
75
4.46
13.57
1.2
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
57
190
3.06
13.47
1.5
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
40
106
3.84
13.45
1.1
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
34
81
4.26
13.18
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
34
81
4.26
13.18
1.1
1.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
193
1107
1.83
12.91
6.6
3.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
27
54
5.06
12.90
3.0
1.7
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
14
13
10.84
12.86
1.1
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
44
129
3.47
12.79
3.9
2.5
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
40
110
3.70
12.78
1.6
1.3
e6/l
45573.2
94055.0
0.35
23
59
(3035637) Corticotropin [Mass/volume] in Plasma
60
214
2.87
12.60
2.3
1.6
—
—
—
0
0
(3010421) pH of Blood
84
355
2.43
12.60
6.6
4.0
ph
7.4
7.4
0.43
73
281
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
185
1057
1.83
12.53
2.5
2.4
au/ml
14.0
21.9
—
8
61
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
94
419
2.31
12.51
2.1
1.7
mg/l
462.9
483.8
0.23
89
396
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
52
172
3.08
12.47
1.2
1.4
pmol/l
656.1
380.4
0.51
40
136
(3012516) Albumin [Mass/volume] in Urine
531
3948
1.49
12.45
4.4
3.3
mg/l
1720.1
279.9
3.22
349
2503
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
55
189
2.97
12.35
1.3
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1331
11783
1.48
12.01
5.0
4.0
pmol/l
14.8
14.7
1.36
1250
10838
(3011985) Renin [Units/volume] in Plasma
53
183
2.95
11.81
1.5
1.4
mu/l
178.7
101.8
0.41
47
164
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
21
36
5.89
11.80
1.1
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
28
63
4.50
11.68
2.1
1.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1425
12815
1.51
11.67
40.5
16.0
%
14.0
13.6
19.51
1412
12548
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
24
48
5.05
11.48
2.5
3.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
362
2521
1.54
11.47
3.3
2.9
mmol/l
2.5
2.4
0.73
311
2211
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
83
367
2.32
11.28
1.7
1.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
90
412
2.25
11.27
15.6
7.1
mmol/l
1.5
1.3
0.63
74
356
(3041096) Erythrocytes [Presence] in Urine by Automated
522
3942
1.45
11.07
5.5
3.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
16
22
7.33
10.99
1.7
1.4
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
38
112
3.44
10.99
1.1
1.1
u/ml
31.0
36.3
—
6
6
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
49
169
2.95
10.96
1.2
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
253
1636
1.63
10.96
24.7
22.7
inr
1.2
1.3
0.33
23
239
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
104
513
2.09
10.81
13.8
6.1
%
1.9
1.6
0.62
94
480
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
98
473
2.13
10.78
1.5
1.3
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
16
9
17.92
10.72
1.4
1.1
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
46
155
3.02
10.72
1.3
1.5
iu/ml
26.4
28.7
—
5
10
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
16
23
7.01
10.58
1.4
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
16
23
7.01
10.58
1.4
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
16
23
7.01
10.58
1.4
1.0
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
10
0
+∞
10.42
1.2
0.0
—
—
—
0
0
(3002256) Pathology report gross observation
278
1866
1.58
10.28
1.3
1.3
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
98
482
2.09
10.28
5.9
4.0
mmol/l
1.3
1.4
0.48
91
474
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
82
376
2.24
10.25
2.2
1.9
e6/l
5.4
20.6
0.96
68
285
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
82
376
2.24
10.25
2.2
1.9
e6/l
74.4
1553.1
1.21
70
298
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
33
93
3.60
10.22
1.3
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
58
228
2.59
10.17
1.3
1.1
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
14
18
7.83
10.15
1.6
1.6
ng/l
122.9
181.4
—
7
12
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
50
183
2.78
10.07
1.2
1.3
nmol/l
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
426
3151
1.46
9.91
5.7
3.9
kg/l
1.0
1.0
0.27
42
457
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
27
68
4.02
9.78
2.3
1.8
ug/l
22.1
140.5
0.48
27
58
(3044290) Cell count panel - Cerebral spinal fluid
76
345
2.26
9.75
2.2
2.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
15
22
6.87
9.74
1.7
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
49
181
2.75
9.71
2.4
2.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
49
181
2.75
9.71
2.0
2.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
73
327
2.28
9.66
2.0
3.6
umol/l
28.1
36.7
3.88
63
285
(3020682) Albumin/Creatinine [Ratio] in Urine
535
4144
1.41
9.63
5.2
4.0
mg/mmol
25.2
8.4
3.63
352
2619
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
427
3183
1.45
9.48
1.9
1.6
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
16
26
6.20
9.46
4.4
4.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
18
33
5.50
9.45
1.2
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
18
33
5.50
9.45
1.2
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
18
33
5.50
9.45
1.2
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
18
33
5.50
9.45
1.2
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
62
261
2.42
9.44
1.2
1.2
u/ml
1.5
3.5
1.15
22
81
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
45
162
2.82
9.36
1.4
1.7
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
15
23
6.57
9.36
2.3
1.6
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
12
14
8.62
9.35
3.1
2.0
umol/l
43.4
36.4
0.53
12
14
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
26
66
3.98
9.33
1.1
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
36
115
3.17
9.21
1.9
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
182
1130
1.68
9.20
2.9
2.5
ml/min/173m2
61.1
69.4
1.61
88
448
(3002523) Influenza virus A Ag [Presence] in Specimen
66
290
2.32
9.15
1.2
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
22
50
4.44
9.09
1.5
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
60
254
2.41
9.04
1.2
1.2
u/ml
4.6
5.5
0.19
24
105
(3043409) Potassium [Moles/volume] in Arterial blood
83
404
2.10
8.97
6.4
4.1
mmol/l
3.8
3.9
0.04
75
378
(3003181) Sodium [Moles/volume] in Urine
58
243
2.43
8.94
1.6
1.5
mmol/l
69.0
64.8
0.32
49
202
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
16
28
5.76
8.80
4.3
6.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
65
290
2.29
8.71
1.2
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
19
40
4.79
8.59
2.1
1.9
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
146
870
1.74
8.58
1.8
1.5
iu/l
18.6
27.8
3.77
128
727
(3044889) 12 lead EKG panel
1142
10092
1.35
8.56
4.8
3.5
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
97
511
1.95
8.46
14.7
6.1
%
1.0
0.9
1.11
88
478
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
12
16
7.54
8.41
1.5
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
71
334
2.17
8.39
2.3
1.7
e6/l
19628.6
12868.3
0.35
55
241
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
32
101
3.21
8.37
1.2
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
38
133
2.90
8.35
1.1
1.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
59
258
2.33
8.30
2.1
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1138
10077
1.34
8.26
5.2
3.1
u/l
56.8
45.4
3.56
1084
9479
(36660697) Celiac disease serology panel - Serum
205
1348
1.59
8.23
1.2
1.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
21
50
4.24
8.20
6.1
3.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
58
254
2.33
8.13
1.1
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
35
119
2.98
8.10
1.3
1.5
umol/l
11.2
11.3
0.04
35
110
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
10
11
9.14
8.09
3.2
4.5
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
10
11
9.14
8.09
3.1
4.5
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
22
55
4.04
8.07
1.2
1.1
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
1678
15927
1.66
8.07
37.9
14.8
umol/l
81.1
73.8
6.88
1678
15920
(3018572) Chloride [Moles/volume] in Blood
62
283
2.23
7.90
20.5
8.6
mmol/l
104.9
105.3
0.33
55
255
(3039000) Anion gap in Blood
62
283
2.23
7.90
20.5
8.6
mmol/l
11.2
11.5
0.24
55
255
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
22
56
3.96
7.89
1.2
1.1
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
21
52
4.07
7.81
1.1
1.4
%
93.2
92.1
—
9
31
(21494567) Legionella sp IgM Ab [Presence] in Serum
12
8
15.08
7.71
1.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
12
8
15.08
7.71
1.0
1.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1488
13809
1.42
7.63
27.3
11.9
ml/min/173m2
84.0
83.9
0.04
1339
11296
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
21
53
4.00
7.62
1.3
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
58
262
2.25
7.59
1.3
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
25
72
3.51
7.55
4.7
3.3
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
47
195
2.45
7.45
2.8
2.9
nmol/l
22.4
20.8
0.34
47
186
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
21
54
3.92
7.43
1.1
1.1
%
93.9
89.9
—
9
32
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
18
41
4.42
7.43
1.2
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
34
120
2.87
7.39
1.9
1.6
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
22
59
3.76
7.36
1.2
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
39
149
2.65
7.31
1.2
1.1
—
—
—
0
0
(4268621)
42
167
2.55
7.28
2.1
2.3
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
39
150
2.63
7.22
3.2
4.6
u/ml
37.4
120.9
0.93
11
44
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
169
1101
1.59
7.06
2.6
2.3
ug/l
5.2
7.1
1.45
145
984
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
18
43
4.22
7.01
1.3
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
155
991
1.62
6.99
2.9
2.2
nmol/l
12.6
12.3
0.18
133
871
(40758292) HTLV I+II Ab panel - Serum
14
27
5.22
6.97
1.1
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1674
15957
1.59
6.95
23.4
9.9
u/l
27.1
26.1
1.47
1648
15440
(3008898) HLA-B27 [Presence]
101
576
1.80
6.93
1.1
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
21
57
3.72
6.92
1.2
1.1
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
12
20
6.03
6.91
3.6
2.6
mg/l
0.8
2.3
—
7
15
(4034850)
84
453
1.90
6.88
15.6
9.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
38
148
2.60
6.88
1.1
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
57
267
2.17
6.86
1.1
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
17
40
4.28
6.75
1.4
1.2
—
—
—
0
0
(3036603) Volume of Urine
29
99
2.96
6.70
1.9
1.4
ml
1208.0
2092.4
—
5
16
(3044941) Cell count panel - Synovial fluid
49
220
2.26
6.55
1.8
1.4
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
13
25
5.23
6.49
2.5
3.0
—
12.6
—
0
5
(40761511) CBC panel - Blood by Automated count
1655
15774
1.53
6.43
29.5
12.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
39
160
2.47
6.37
2.2
1.7
%
63.7
58.3
0.41
27
105
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
42
179
2.38
6.33
1.2
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1483
13868
1.37
6.32
6.1
4.8
mu/l
1.9
2.2
0.91
1414
12814
(3000012) Reticulocyte production index
23
71
3.27
6.28
1.6
1.7
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
6
0
+∞
6.25
1.3
0.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
43
188
2.32
6.13
1.2
1.1
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
11
19
5.82
6.11
5.0
4.5
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
10
8
12.56
6.08
9.3
9.9
—
—
—
0
0
(4027681)
29
105
2.79
6.06
1.2
1.2
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
27
95
2.87
5.95
1.1
1.1
ratio
1.2
1.0
—
9
41
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
9
6
15.06
5.90
1.1
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
23
74
3.14
5.90
1.1
1.1
miu/ml
1209.6
1656.2
0.83
23
74
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
167
1131
1.52
5.89
1.5
1.2
iu/ml
53.8
144.5
7.15
68
431
(3024928) Oxygen saturation in Venous blood
60
305
2.00
5.88
22.1
4.8
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
20
59
3.42
5.87
1.2
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
99
592
1.71
5.81
1.6
1.6
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
24
80
3.03
5.81
1.5
1.3
nmol/l
121.0
146.5
1.53
24
80
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
11
20
5.53
5.81
1.2
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
181
1253
1.49
5.75
8.7
3.7
—
—
—
0
0
(4306422)
52
254
2.08
5.68
1.2
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
37
157
2.38
5.66
3.0
7.1
mmol/l
6.6
7.2
0.41
31
129
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
10
17
5.91
5.63
16.4
7.6
mmol/l
5.0
7.0
—
10
17
(3024471) HLA-A [Type]
19
56
3.42
5.59
1.0
1.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
193
1362
1.47
5.58
3.7
4.2
ug/l
13.5
23.0
0.41
149
1097
(3025018) Bordetella pertussis Ab [Titer] in Serum
30
116
2.61
5.56
1.3
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
27
99
2.75
5.54
1.3
1.1
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
11
21
5.26
5.52
1.6
2.8
mmol/l
18.3
17.0
0.10
11
21
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
20
62
3.25
5.45
3.1
5.8
mg/l
6.6
8.1
0.54
15
56
(3035880) pH of Pleural fluid
20
62
3.25
5.45
1.4
1.1
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
8
5
16.07
5.41
1.1
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
449
5427
0.77
5.31
2.9
2.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
56
289
1.97
5.29
1.4
1.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
27
102
2.67
5.25
1.7
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
31
127
2.47
5.13
1.2
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
19
60
3.19
5.04
1.2
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
18
55
3.30
5.03
1.1
1.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
9
9
10.04
5.02
1.4
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
37
166
2.25
5.02
1.2
1.1
—
—
—
0
0
(3012565) Volume of 24 hour Urine
21
71
2.98
4.99
2.7
2.9
ml
1605.0
1975.3
1.05
21
65
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
77
449
1.75
4.98
1.2
1.1
u/ml
22.9
5.8
—
10
64
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
90
1425
0.61
4.94
1.6
1.7
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
63
347
1.84
4.92
1.1
1.1
u/ml
6.1
6.5
0.07
44
199
(3004716) Salmonella sp identified in Stool by Organism specific culture
131
882
1.52
4.78
1.4
1.4
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
8
7
11.47
4.78
1.1
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
49
251
1.98
4.76
1.1
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
142
975
1.49
4.73
1.2
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
84
511
1.67
4.68
4.3
3.3
u/ml
137.3
2885.5
0.77
74
431
(3025130) Human papilloma virus identified in Specimen
44
219
2.03
4.63
2.1
1.8
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
12
29
4.16
4.63
1.5
1.1
mmol/l
3.4
3.8
0.15
12
23
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
12
29
4.16
4.63
1.4
1.7
—
—
—
0
0
(3013512) EKG study
472
3937
1.27
4.56
4.8
3.6
—
—
—
0
0
(3048879) Bone marrow aspiration report
13
34
3.84
4.53
1.2
1.8
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
10
21
4.78
4.53
1.0
1.2
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
51
270
1.91
4.52
1.6
1.1
iu/ml
62.5
1845.9
0.51
12
71
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
8
8
10.04
4.52
4.4
4.4
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
28
117
2.41
4.48
1.1
2.2
u/field
1.9
2.1
0.14
23
54
(3028707) Methadone [Presence] in Urine by Screen method
56
307
1.85
4.47
2.1
3.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
16
49
3.29
4.47
2.6
2.3
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
12
30
4.02
4.44
1.1
1.3
ug/l
0.4
0.3
—
7
20
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
32
144
2.24
4.35
1.2
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
16
50
3.22
4.34
1.3
1.0
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
52
282
1.87
4.30
1.7
1.5
nmol/l
0.2
0.4
1.71
43
222
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
76
462
1.67
4.28
1.9
1.7
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
6
11.70
4.27
5.7
7.2
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
7
6
11.70
4.27
1.1
1.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
97
627
1.58
4.27
2.4
2.3
u/l
5819.4
3762.9
0.24
29
253
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
26
108
2.43
4.23
2.8
1.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
126
865
1.49
4.22
2.1
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
211
1592
1.37
4.20
1.7
1.7
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
15
46
3.28
4.19
2.5
2.5
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
14
41
3.43
4.18
1.4
1.5
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
14
41
3.43
4.18
1.1
1.2
pmol/l
271.0
304.1
—
9
29
(3045424) Erythrocytes [Presence] in Urine
46
243
1.92
4.13
1.9
1.4
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
10
23
4.37
4.09
1.3
1.3
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
23
4.37
4.09
1.2
1.0
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
84
534
1.60
3.99
1.4
1.3
miu/ml
236.6
222.2
0.12
36
256
(44813793)
25
105
2.40
3.98
1.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
11
28
3.95
3.98
1.0
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
107
720
1.52
3.96
2.6
2.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
19
70
2.73
3.92
4.0
1.6
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
7
8
8.78
3.77
1.4
1.5
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
6
5
12.03
3.76
1.2
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
25
108
2.33
3.76
3.6
2.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
122
853
1.46
3.76
3.6
3.1
u/ml
39.6
52.4
0.56
116
822
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
18
66
2.74
3.75
1.1
1.1
ng/l
1081.0
239.7
—
5
15
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
233
1820
1.32
3.69
1.6
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
458
3892
1.24
3.66
1.7
1.7
mmol/l
1.4
1.4
0.49
404
3299
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
23
97
2.39
3.65
1.2
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
22
91
2.43
3.64
1.5
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
151
1105
1.40
3.64
2.2
1.9
—
—
—
0
0
(3019225) pH of Specimen
182
1374
1.36
3.63
8.6
3.9
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
38
199
1.93
3.54
3.3
2.3
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
6
6
10.03
3.50
1.7
5.0
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
6
6
10.03
3.50
1.0
1.5
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
11
31
3.56
3.48
4.2
1.9
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
15
52
2.90
3.46
1.5
1.0
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
23
100
2.32
3.43
2.5
1.5
umol/l
3.7
4.5
0.46
23
93
(3008401) Mugwort IgE Ab [Units/volume] in Serum
56
335
1.69
3.41
1.1
1.1
u/ml
0.4
1.2
1.12
36
171
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
44
246
1.81
3.37
1.0
1.1
u/ml
2.5
2.1
—
6
109
(44786800) Granulocytes/100 leukocytes in Body fluid
7
10
7.02
3.36
1.6
1.4
%
18.4
6.6
—
7
5
(21494755) Public health laboratory ask at order entry panel
113
1572
0.70
3.35
1.3
1.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
10
27
3.72
3.35
1.6
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
14
5.73
3.34
1.3
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
26
121
2.17
3.32
14.8
7.5
%
10.6
11.2
0.41
26
121
(3045414) Leukocytes [Presence] in Urine
95
649
1.49
3.32
2.4
1.8
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
31
155
2.02
3.30
2.6
2.5
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
9
19
4.75
3.24
1.0
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
23
103
2.25
3.23
1.3
1.1
u/l
1.0
1.1
—
9
53
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
10
28
3.59
3.19
1.6
1.3
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
14
49
2.87
3.19
1.4
1.2
nmol/l
116.9
108.1
—
7
37
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
8
15
5.35
3.19
1.3
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
7
11
6.38
3.18
1.0
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
67
2.55
3.13
1.4
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
14
50
2.81
3.09
1.1
1.1
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
6
8
7.52
3.05
2.8
4.5
—
—
—
0
0
(3025315) Body weight
6
8
7.52
3.05
6.2
2.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
24
113
2.14
3.01
1.5
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
16
63
2.55
2.96
2.5
2.6
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
11
35
3.16
2.93
5.7
6.7
g/mol
204.9
82.8
0.28
11
30
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
11
35
3.16
2.93
1.2
1.2
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
8
17
4.72
2.92
1.0
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
10
30
3.35
2.90
1.8
1.1
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
15
58
2.60
2.87
2.2
1.3
%
1.6
5.1
—
5
12
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
16
64
2.51
2.87
2.4
2.5
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
6
9
6.68
2.87
2.7
2.3
mg/l
2.8
4.5
—
6
9
(3020356) Listeria sp identified in Specimen by Organism specific culture
6
9
6.68
2.87
1.0
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
53
329
1.63
2.85
1.1
1.1
u/ml
3.5
3.8
0.03
18
83
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
54
338
1.62
2.82
1.9
2.5
nmol/l
1.1
0.8
0.90
42
285
(3010144) Erythrocytes [#/volume] in Synovial fluid
26
130
2.01
2.81
1.8
1.4
e6/l
400438.0
89778.3
0.52
18
89
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
34
187
1.83
2.79
2.0
1.5
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
37
209
1.79
2.79
2.7
2.8
umol/l
10.7
8.3
0.38
31
155
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
67
988
0.67
2.75
1.4
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
42
2.87
2.75
1.1
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1394
14513
0.83
2.75
4.7
4.2
mmol/l
1.4
1.5
2.77
1300
13454
(3026480) Teichoate Ab [Titer] in Serum
6
10
6.02
2.70
1.2
1.2
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
11
37
2.98
2.69
1.3
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
8
19
4.22
2.68
2.5
3.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
9
24
3.76
2.67
1.0
1.1
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
13
49
2.66
2.62
2.5
2.8
e6/l
11936.4
34426.0
—
7
33
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
15
61
2.47
2.62
1.7
3.5
umol/l
81.0
129.9
—
8
38
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
23
113
2.05
2.62
2.2
1.5
%
27.4
33.0
0.42
13
71
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
58
378
1.55
2.58
1.3
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
67
451
1.50
2.58
3.0
3.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
76
527
1.46
2.53
2.0
2.6
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
59
388
1.54
2.53
1.1
1.1
u/ml
0.6
3.0
2.96
38
181
(3023511) Choriogonadotropin [Units/volume] in Urine
53
340
1.58
2.53
1.3
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
10
33
3.04
2.52
1.1
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
7
16
4.39
2.47
1.6
1.4
ng/l
53.6
93.9
—
7
16
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
16
4.39
2.47
1.4
1.3
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
10
34
2.95
2.41
1.1
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
9
27
3.34
2.39
1.2
1.3
—
—
—
0
0
(4212803)
5
8
6.26
2.37
1.0
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1408
14599
0.84
2.36
4.7
4.2
mmol/l
4.6
4.7
4.25
1327
13622
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
59
395
1.51
2.35
2.1
1.7
nmol/l
43.2
40.4
0.30
59
380
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
30
170
1.78
2.29
3.0
2.4
mg/l
27.3
27.9
0.03
12
47
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1345
13986
0.85
2.27
4.3
3.8
mmol/l
1.4
1.3
8.31
1249
12911
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
6
13
4.63
2.27
2.0
4.3
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
6
13
4.63
2.27
1.7
4.3
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
44
278
1.60
2.27
2.2
1.9
pmol/l
184.4
209.8
0.85
37
264
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
7
18
3.90
2.25
1.0
1.1
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
7
18
3.90
2.25
3.7
3.3
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
18
3.90
2.25
1.1
1.3
—
—
—
0
0
(3049233) Organic acids panel - Urine
5
9
5.57
2.21
1.0
1.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
22
115
1.92
2.16
1.1
1.5
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
5
10
5.01
2.07
1.0
2.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
12
50
2.41
2.02
1.1
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
16
76
2.12
2.02
1.2
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1437
14828
0.85
2.00
5.1
4.6
mmol/l
2.7
2.8
4.96
1334
13748
(3001686) Cold agglutinin [Titer] in Serum or Plasma
9
32
2.82
2.00
1.1
1.4
—
191.3
—
0
6
(3004451) EKG impression Narrative
14
64
2.20
1.94
1.1
1.3
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
5
11
4.55
1.94
1.0
1.2
u/l
4.0
10.9
—
5
11
(3027974) Hepatitis B virus e Ag [Presence] in Serum
5
11
4.55
1.94
1.0
1.9
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
21
113
1.87
1.92
1.5
1.5
promille
1.2
1.4
0.21
15
91
(3003338) MCHC [Mass/volume]
1365
13143
1.15
1.91
41.1
16.7
g/l
330.9
332.5
8.27
1359
13056
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
7
22
3.19
1.88
1.4
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
82
613
1.35
1.86
2.1
2.6
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
17
3.54
1.84
1.7
1.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
40
2.51
1.83
2.8
2.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
40
2.51
1.83
2.8
2.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
38
572
0.66
1.82
1.7
1.8
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
13
60
2.18
1.78
2.8
2.9
e6/l
41816.5
782.1
—
8
53
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
218
1849
1.20
1.77
1.8
1.8
%
1.5
1.4
0.95
193
1638
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
18
3.34
1.74
1.0
1.1
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
21
117
1.80
1.74
1.0
1.1
u/ml
0.4
1.6
—
9
52
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
12
54
2.23
1.74
1.0
1.0
—
—
—
0
0
(1002224) Polysomnography panel
87
664
1.33
1.74
1.1
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
5
13
3.85
1.71
1.0
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
86
659
1.32
1.68
2.1
2.5
—
—
—
0
0
(3014891) Appearance of Pleural fluid
6
19
3.16
1.66
3.0
1.5
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
7
26
2.70
1.58
2.4
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
86
666
1.31
1.57
2.1
2.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
11
50
2.21
1.57
1.2
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
18
100
1.81
1.53
2.1
4.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
6
21
2.86
1.50
1.5
2.4
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
35
234
1.51
1.50
1.1
1.1
u/ml
1.1
7.2
3.85
18
96
(3014133) Dog dander IgE Ab [Units/volume] in Serum
38
259
1.48
1.48
1.1
1.1
u/ml
6.9
5.4
0.11
20
101
(3027008) Opiates [Presence] in Urine
85
664
1.29
1.47
2.1
2.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
84
656
1.29
1.46
1.8
2.4
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
15
80
1.88
1.44
1.4
1.6
nmol/l
1.2
1.2
—
9
62
(3009542) Hematocrit [Volume Fraction] of Blood
1454
14147
1.14
1.42
35.0
14.1
%
39.3
39.8
1.71
1089
10662
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
9
40
2.26
1.40
7.3
6.4
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
10
46
2.18
1.40
1.0
1.3
—
3.1
—
0
8
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
55
409
1.36
1.36
1.9
1.9
iu/l
2.8
4.7
1.92
14
146
(3014599) Egg white IgE Ab [Units/volume] in Serum
21
128
1.65
1.33
1.0
1.2
u/ml
16.5
2.6
0.39
11
49
(3027231) Wheat IgE Ab [Units/volume] in Serum
11
54
2.04
1.33
1.2
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
70
895
0.77
1.32
2.4
1.7
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1713
16897
1.22
1.29
50.6
19.2
e9/l
252.0
255.9
1.33
1692
16487
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
13
69
1.89
1.28
1.3
1.1
iu/ml
121.1
255.8
1.67
13
69
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
8
35
2.29
1.27
1.3
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
60
460
1.31
1.23
2.1
2.5
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
10
49
2.05
1.22
1.2
1.3
—
—
—
0
0
(3035941) MCH [Entitic mass]
1713
16908
1.21
1.21
50.3
19.1
pg
30.0
30.2
2.76
1702
16694
(3026361) Erythrocytes [#/volume] in Blood
1713
16909
1.21
1.20
50.5
19.2
e12/l
4.4
4.5
11.90
1686
16463
(3038071) Oxygen [Partial pressure] in Mixed venous blood
8
38
2.11
1.18
8.1
6.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
12
64
1.88
1.18
1.2
1.2
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
34
0.00
1.16
0.0
1.8
—
2.2
—
0
13
(3045716) Anion gap in Serum or Plasma
13
72
1.81
1.15
3.5
2.0
mmol/l
7.8
9.1
—
7
56
(3024731) MCV [Entitic volume]
1712
16905
1.21
1.15
50.3
19.2
fl
90.5
90.5
0.06
1701
16695
(3000963) Hemoglobin [Mass/volume] in Blood
1713
16916
1.21
1.14
50.9
19.3
g/l
130.7
135.1
27.02
1702
16699
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
110
920
1.21
1.11
1.0
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
44
582
0.75
1.10
1.3
1.5
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
5
21
2.38
1.09
5.6
2.9
umol/l
28.0
44.4
—
5
16
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
5
21
2.38
1.09
1.0
1.0
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1712
16914
1.20
1.08
50.6
19.3
e9/l
7.3
6.7
5.87
1686
16465
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
10
52
1.93
1.06
1.9
1.7
pmol/l
15.2
14.3
—
10
43
(3032868) Hemoglobin electrophoresis panel in Blood
5
22
2.28
1.03
1.6
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
73
592
1.24
1.01
1.7
1.4
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(44806071)
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(4281824)
24
165
1.46
0.97
1.3
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
13
77
1.69
0.95
1.3
1.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1367
13364
1.09
0.89
6.6
5.4
mmol/mol
39.9
39.3
1.08
1297
12446
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
35
459
0.76
0.87
1.5
1.5
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
31
1.94
0.84
1.5
1.2
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
20
139
1.44
0.79
1.1
1.4
nmol/l
1.8
1.4
0.59
20
125
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
33
1.82
0.79
1.3
1.5
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
6
34
1.77
0.76
1.5
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
15
221
0.68
0.76
1.6
1.6
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
13
83
1.57
0.75
2.3
2.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
195
1767
1.12
0.74
2.2
2.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
7
38
1.85
0.73
2.3
3.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
41
512
0.80
0.73
1.6
1.4
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
25
2.00
0.72
2.4
2.4
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
25
2.00
0.72
1.2
1.1
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
5
25
2.00
0.72
1.8
1.1
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
5
25
2.00
0.72
7.0
3.0
u/l
1702.8
3341.6
—
5
25
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
5
25
2.00
0.72
10.2
8.3
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
26
1.93
0.70
1.0
1.2
umol/24h
1.6
1.7
—
5
26
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
29
221
1.32
0.70
1.0
1.0
u/ml
0.1
0.8
0.99
12
60
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
215
1967
1.11
0.69
2.3
2.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
27
1.85
0.68
1.0
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
30
385
0.78
0.67
1.4
1.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
5
28
1.79
0.66
1.6
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
26
339
0.76
0.66
1.7
1.7
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
11
70
1.57
0.65
1.1
1.0
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
17
120
1.42
0.64
2.5
3.1
mg/l
370.6
21.7
0.49
12
93
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
34
425
0.80
0.63
1.4
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
79
683
1.16
0.63
4.4
3.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
34
424
0.80
0.62
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
34
424
0.80
0.62
1.4
1.4
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
8
50
1.60
0.61
2.6
2.9
umol/l
22.1
31.6
—
8
35
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
34
423
0.80
0.61
1.4
1.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
9
141
0.64
0.60
1.1
1.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
41
338
1.22
0.56
3.0
2.4
ug/min
154.8
103.3
0.35
32
209
(3036071) Salmonella sp Ab [Titer] in Serum
9
61
1.48
0.53
1.0
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
39
1.54
0.53
1.0
2.4
umol/l
29.1
18.4
—
6
39
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
14
100
1.40
0.51
3.3
1.7
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
9
64
1.41
0.51
1.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
11
75
1.47
0.50
3.0
2.8
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
9
65
1.39
0.50
3.1
3.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
6
41
1.46
0.50
1.0
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
40
334
1.20
0.50
5.2
4.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
7
45
1.56
0.49
3.3
2.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
69
782
0.88
0.47
1.6
1.6
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
7
49
1.43
0.46
2.1
1.4
ug/l
12.9
9.0
—
7
49
(4024509)
17
129
1.32
0.45
2.1
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
36
302
1.20
0.44
3.9
3.6
mg/l
29.6
23.4
0.46
23
192
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
31
1.61
0.43
1.4
3.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
39
331
1.18
0.43
3.0
2.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
8
58
1.38
0.41
1.5
1.6
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
5
33
1.52
0.41
5.2
5.4
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
5
33
1.52
0.41
2.6
2.7
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
12
88
1.37
0.40
8.0
6.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
264
2778
0.94
0.39
4.0
4.0
%
21.6
21.4
0.07
122
1253
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(4094501)
43
372
1.16
0.39
1.1
1.1
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
15
115
1.31
0.39
1.4
1.2
nmol/l
364.3
399.2
0.31
15
106
(3043238) Trisomy 21 risk [Likelihood] in Fetus
30
356
0.84
0.39
1.4
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
31
261
1.19
0.38
1.8
1.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
32
376
0.85
0.37
1.6
1.6
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
13
98
1.33
0.37
8.1
12.3
mmol/l
0.7
0.6
0.65
13
89
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
23
279
0.82
0.37
1.5
1.5
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
44
383
1.15
0.37
1.6
1.5
pmol/l
134.0
169.4
0.26
44
377
(3027456) Digoxin [Moles/volume] in Serum or Plasma
27
225
1.20
0.37
3.8
3.1
nmol/l
0.8
0.8
0.03
17
177
(3051593) INR in Capillary blood by Coagulation assay
6
47
1.28
0.32
12.0
11.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
30
348
0.86
0.31
1.4
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
159
1685
0.94
0.31
1.8
1.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
192
2021
0.94
0.30
2.8
2.9
ug/l
0.8
0.8
0.03
138
1264
(3005033) Fetal Nuchal fold Thickness US
30
346
0.86
0.30
1.4
1.4
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
15
121
1.24
0.28
1.8
1.5
g/l
0.8
1.0
1.28
15
121
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
27
234
1.16
0.26
1.4
1.5
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
84
0.71
0.24
1.2
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
17
201
0.84
0.23
1.4
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
16
190
0.84
0.23
1.3
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
176
1686
1.05
0.22
12.8
6.6
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
5
40
1.25
0.22
1.4
1.0
u/ml
29.9
39.3
—
5
40
(3003694) ABO and Rh group [Type] in Blood
439
4288
1.03
0.21
1.6
1.5
—
—
—
0
0
(3001729) Color of Synovial fluid
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
6.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
18
154
1.17
0.21
2.4
2.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
100
946
1.06
0.20
3.6
2.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
281
2728
1.04
0.20
1.7
1.4
—
—
—
0
0
(4198724)
10
81
1.24
0.18
1.3
4.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
66
622
1.06
0.16
2.1
1.6
mg/l
4.7
4.1
0.16
50
435
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
6
77
0.78
0.15
1.5
1.4
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
6
56
1.07
0.08
1.8
1.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
173
1699
1.02
0.07
4.9
4.3
%
31.7
32.2
0.24
140
1167
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
9
87
1.03
0.07
1.2
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
9
101
0.89
0.06
1.8
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
17
182
0.93
0.05
1.1
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
343
3456
0.99
0.04
4.3
4.6
ug/l
2.4
2.9
0.44
315
3093
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1419
14216
0.99
0.04
5.1
4.2
mmol/l
5.9
5.9
0.91
1339
13012
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
10
94
1.06
0.01
4.0
1.7
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
12
126
0.95
0.00
1.3
1.2
—
—
—
0
0
(4146454)
13
131
0.99
0.00
4.1
2.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
25
251
1.00
0.00
1.2
1.3
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
6
59
1.02
0.00
2.5
2.8
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
1.0
—
7.7
—
0
7
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
1.0
—
21.7
—
0
7
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
14.4
—
0
8
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
7
0.00
0.00
0.0
1.0
—
1431.1
—
0
7
(40758358) Immune stain study
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
0.1
—
0
6
(4211845)
6
67
0.90
0.00
2.5
2.7
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
1.0
—
38.4
—
0
7
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022670) pH of Venous cord blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
8
0.00
0.00
0.0
1.1
—
7.6
—
0
8
Mortality – FinRegistry
↥Association
Association between endpoint D3_IMMUDEF and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_IMMUDEF | 2.207 [1.97, 2.48] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.33 |
During the follow-up period (1.1.1998 — 31.12.2019), 1143 out of 5305 females with D3_IMMUDEF died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_IMMUDEF | 2.277 [1.99, 2.6] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.016 |
During the follow-up period (1.1.1998 — 31.12.2019), 1047 out of 3714 males with D3_IMMUDEF died.
Mortality risk
Mortality risk for people of age
years, who have D3_IMMUDEF.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.213% | 0.443% |
| 5 | 1.299% | 2.692% |
| 10 | 3.201% | 6.61% |
| 15 | 6.311% | 12.155% |
| 20 | 10.873% | 20.671% |
Relationships between endpoints
↥Index endpoint: D3_IMMUDEF – Immunodeficiencies
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data